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Abstract
The main objective of this thesis was to examine the role of purinergic 
signalling in the contraction of the smooth muscle of the genito-urinary tract of 
laboratory animals and compare it to that of man. It also examined purinergic 
signalling in the maturation of sperm within the epididymis.
The main methodology involved organ bath studies on the functional 
physiology of smooth muscle contraction, in conjunction with immunohistochemical 
examination of smooth muscle P2X receptor expression.
In Chapter 3, a comparative study of the smooth muscle cells of the testicular 
capsule or tunica albuginea of the testis from man, mouse, rat and rabbit was made. 
The smooth muscle cell arrangement was demonstrated by electron microscopy, and 
the role of purinergic co-transmission in the contraction of this smooth muscle was 
investigated.
Chapter 4 examined purinergic signalling in the contraction of the human vas 
deferens smooth muscle.
P2X receptors are involved in cell-to-cell signalling. Chapter 5 was a 
comparative study of the expression of P2X receptors on sperm contained within the 
head and tail of the epididymides of mice, rats, hamsters and man. This study 
demonstrated changing expression with maturity.
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Alterations in the relative purinergic and cholinergic components of detrusor 
contraction have been demonstrated in the over active bladder. Chapter 6 details the 
partial bladder outlet obstruction model that was developed in the rat. This model 
demonstrated an up-regulation of the cholinergic component of detrusor contraction 
with no significant change in the purinergic component, which implied the rat 
detrusor adapts to outflow obstruction in a different manner to the human detrusor.
In Chapter 7, a general discussion of the role of purinergic signalling in the 
genito-urinary tract is given. The extent of how well the hypothesis was tested is 
considered in this chapter and future directions are suggested.
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Preface and hypothesis
ATP, as an extracellular signalling molecule, under the broad umbrella of 
purinergic signalling, probably represents a primitive signalling system, being present 
throughout animal phyla. However, research into purinergic signalling remains a 
relatively new field, and it is only recently that the field has rapidly advanced. The 
cloning of P2 receptors and modem techniques of gene or protein recognition have 
identified P2 receptor expression in a huge variety of tissues. The field has therefore 
jumped from the co-transmission explanation of non-adrenergic, non-cholinergic 
(NANC) smooth muscle contraction, to include a rapidly increasing range of 
biological functions. P2 receptors are now thought to mediate endocrine and epithelial 
cell secretion, nociception, cell differentiation, maturation and apoptosis to name only 
a few functions (Bumstock and Knight 2004).
An observation of purinergic signalling is that animal studies are not 
necessarily replicated in man, and in healthy tissues the significance of purinergic 
signalling may be different to than that demonstrated in animals. However, in certain 
human pathological states, the significance of purinergic signalling is altered, which 
potentially leads to the exciting prospect of pharmacological therapy. In this study, I 
attempted to include human tissue to identify similarities and differences between 
animal and human tissue.
The therapies for male infertility are extremely limited, other than surgical 
bypass for tubular blockage. The success of intra cytoplasmic sperm injection (ICSI) 
in achieving fertilisation, even with immature testicular sperm, has focussed research 
away from the factors causing male factor infertility into the mechanism of embryo
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implantation and the maintenance of pregnancy. The very basis of normal sperm 
production, maturation and transportation through the genital tract is incompletely 
understood, and much ‘evidence’ is implied from anatomical studies. Objective 
evidence for how a sperm is propelled from the seminiferous tubule into the 
epididymis, through the genital tract and subsequently ejaculated, is extremely 
limited. There is very limited evidence for contractions of the seminiferous tubules, 
and, as non-ejaculated sperm are quiescent, the passage of sperm from the testis into 
the epididymis must be down a pressure gradient. I therefore examined the contractile 
properties of the tunica albuginea of the testis, which is generally thought to be an 
acontractile fibrous sac, despite its obvious natural tone, demonstrable by the 
immediate extrusion of seminiferous tubules on puncture. The smooth muscle cell 
phenotype and distribution was examined, and the role of purinergic signalling in the 
contraction of this smooth muscle was investigated. The natural progression from this 
was to examine the role of purinergic signalling in the vas deferens. Despite the fact 
that the most convincing evidence for purinergic co-transmission was undertaken in 
the vas deferens of animals, and P2Xi receptors were cloned from the rat vas 
deferens, few reports of purinergic function in human vas deferens are published. The 
purinergic component of human vas deferens was therefore characterised.
Extracellular ATP is increasingly being shown to have trophic effects on 
cellular differentiation and maturation. The presence of ATP in ejaculated seminal 
fluid is well known, but ATP concentration does not correlate with fertility or sperm 
motility. This is suggestive of a further function for ATP beyond being an energy 
substrate for ejaculated sperm. A chance observation demonstrated P2Xi receptor 
expression on sperm contained in the head of the epididymis, which was subsequently
17
lost on sperm in the tail of the epididymis. The possibility that P2X receptors may be 
involved in the maturation of epididymal sperm was investigated.
The pathological, overactive bladder is a huge clinical problem with poorly 
correlating symptoms and no unifying cause. The mainstay of treatment remains 
anticholinergic medication, which is poorly tolerated, and trials show minimal benefit 
over placebo. The worldwide anticholinergic market is worth over $6 billion a year. 
An up regulation of the normally minimal purinergic component of human detrusor 
contraction has been shown in the over active bladder. Further evidence for purinergic 
up regulation was demonstrated in a rabbit model of partial bladder outflow 
obstruction within this department. The recent development of polyclonal antibodies 
to the seven P2X receptor subtypes, invited the opportunity to examine the P2X 
receptor subtypes involved in the observed purinergic up-regulation of detrusor 
contraction. As the antibodies were prepared in a rabbit, a rat model of partial bladder 
outlet obstruction was developed, and the purinergic component of the obstructed 
detrusor was characterised.
In this thesis I tested the hypothesis that:
“Purinergic signalling in the genito-urinary tract of man may differ from that in 
laboratory animals”.
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CHAPTER 1 
GENERAL INTRODUCTION
1.1 Historical perspective
1.1.1. Extracellular functions of purines
The purine nucleotide adenosine 5’-triphosphate (ATP) can be considered the 
energy molecule of life. It is widely known as the fundamental intracellular energy 
source, and there are few students who do not have some vague recollection of its 
production via the Kreb’s cycle. The role of ATP as an extracellular signalling 
molecule is less well known, and its intracellular role was probably the cause for 
resistance in accepting its function as an extracellular signalling molecule as it seemed 
intuitively unlikely that such an essential compound should have such diverse roles 
both in and outside the cell. The other point of view is that as it is such an 
evolutionary essential molecule, it is not surprising that it has functions beyond being 
an intracellular energy substrate.
The history of ATP as an extracellular signalling compound really began in 
1929 when Drury and Szent-Gyorgi found that a purified white powder extract from 
cardiac muscle, and thought to be adenylic acid, produced heart block, dilated the 
coronary vasculature, caused hypotension and reduced the contractions of isolated 
intestinal strips (Drury et al., 1929). Subsequent studies demonstrated that the 
pharmacological activity of such extracts was largely due to adenosine 5’- 
monophosphate. ATP was subsequently isolated from skeletal muscle by Lohman in 
1931 (Lohman, 1931). At around this time, it became apparent that different 
nucleotides and nucleosides had differing potencies and activities, which appeared to 
relate to the number of phosphate groups (Deuticke, 1932). It was not until the latter 
part of the century that different receptor subtypes were discovered to explain this 
observation. It was likely that early extracts were of mixed purity, and it is probable,
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that this was the reason for the contrasting observations noted in some early 
experiments. The conversion of ATP to active metabolites would also explain some 
opposing observations. For instance in 1933 it was found that ATP injected at a low 
concentration into perfused cat lungs caused vasodilation, but at a high concentration 
caused vasoconstriction (Gaddum and Holtz, 1933). Research interest was directed 
into the actions of purines and principally adenosine on the heart. Clinical studies 
were developed to examine the possibility of adenosine as an anti-arrythmic agent 
(Honey et al., 1930; Jezer et al.; 1933). Richards (1934) found that normal human 
heart rate increased on injection of both adenosine and AMP, but large boluses were 
found to temporarily arrest the heart (Honey et al., 1930). Its short half life limited its 
role but it is still utilised in clinical practice in the diagnosis and treatment of supra­
ventricular tachycardias. The next big advance in demonstrating the extracellular 
action of ATP was made by Holton (1959) who showed that antidromic stimulation of 
sensory nerves caused ATP release, sufficient to cause vasodilation of rabbit ear 
arteries.
Berne (1963) suggested that adenosine mediated coronary vasodilation in 
response to hypoxia. This was based on the demonstration of adenosine metabolites in 
the effluent of hypoxic isolated perfused hearts. He suggested that this was indicative 
of low intracellular ATP stores, and adenosine crossed the sarcolemma to relax 
coronary vascular smooth muscle. More recently, Bumstock (1999) has suggested that 
ATP released from endothelial cells during hypoxic and shear stress, acts on 
endothelial receptors causing the release of the potent vasodilator nitric oxide (NO).
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1.2 Receptors for Adenosine and Purine Nucleotides
The first demonstration that multiple receptors for adenosine and adenine 
nucleotides existed came from Gillespie in 1934. He demonstrated that deamination 
of adenine compounds greatly reduced their pharmacological activity and removal of 
phosphates influenced not only potency, but also the type of response. The ability of 
adenine to cause vasodilation increased following the removal of phosphates, and 
ATP was shown to be more potent than AMP and adenosine in causing contraction of 
guinea-pig ileum and uterus (Gillespie, 1934). This was the first demonstration of 
different actions of adenosine and ATP, and with subsequent hindsight the 
demonstration of the two main families of purine receptors.
This fundamental division in the classification of purine receptors persists 
today. The huge advances in genetics, receptor cloning, and the use recombinant 
receptors in the last few years have rapidly changed and clarified the receptor 
classification. The main division was formally recognised by Burnstock in 1978. He 
proposed that “purinergic” receptors be divided into Pl-purinoceptors, at which 
adenosine was the principal ligand, and P2-purinoceptors at which ATP was the 
principal ligand (Burnstock, 1978). This division was based on the relative potencies 
of ATP, ADP, AMP and adenosine, the selective antagonism of adenosine effects by 
methylxanthines (caffeine and theophylline), activation of adenylate cyclase by 
adenosine and stimulation of prostaglandin synthesis by ATP and ADP.
On the basis of receptor cloning the PI receptor has been further divided into 
four subtypes: Ai, A2A, A zb, and A 3, all of which couple to G proteins. Molecular 
studies have shown them to be structurally distinct and pharmacological profiles 
support this.
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Evidence suggested two different types of P2 receptor distinguishable on 
pharmacological grounds (Bumstock and Kennedy, 1985). P2 receptors were shown 
to be ligand-gated cation channels (Benham and Tsien, 1987), or involved in G 
protein activation (Dubyak, 1993). In the early 1990’s it became apparent that 
different subtypes of receptors existed, there then followed what has been described 
as a “random walk through the alphabet” in the classification of these receptors, 
which included P2x, P2Y, P2U, P2T. Abbrachio and Bumstock revised this unsatisfactory 
classification in 1994. They proposed the division of the P2 receptors into an ion- 
gated P2X family and a G protein-coupled P2Y family (Abbrachio and Burnstock, 
1994). Currently, in mammals, seven subtypes of P2X receptors (P2Xi,2 ,3 ,4 ,5 ,6  a n d  7 )  
receptors and eight subtypes of P2Y receptors (P2Yi,2 , 4 ,6 .1 1 ,1 2 ,1 3  a n d  1 4 )  are recognised. 
Their tissue distribution and pharmacological properties have been defined. (Ralevic 
and Burnstock, 1998; Bumstock, 2003a,b; Bumstock and Knight, 2004)
The classification of purinoceptors has been difficult for a number of reasons. 
It has been shown that often several types of receptor are present within one tissue. 
Agonists are rapidly metabolised by ecto-nucleotidases to active metabolites, for 
instance, ATP is rapidly metabolised to adenosine, whereupon the PI effect may mask 
or counteract the P2 effect, with the result that only the dominant receptor effect is 
seen. Receptor subtypes have differing affinities for agonists. The purinergic field has 
been hampered by a paucity of truly selective subtype antagonists, furthermore many 
antagonists have been to found to inhibit ecto-nucleotidases, and so distort 
pharmacological profiles. The development of subtype receptor gene-deleted mice has 
helped circumvent this problem. It is becoming apparent that receptors form both 
homomultimers, and heteromultimers, and there is also evidence for splice variants of 
some receptors.
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Major advances have been made following the cloning of the receptors. 
Subsequent expression of recombinant receptors in Xenopus oocytes or transfected 
cells has allowed pharmacological characterisation of the specific receptor subtypes. 
Subsequent development of antibodies to the C-terminus of the different receptor 
subtypes has allowed the investigation of tissue distribution, which has revealed a 
wealth of receptor expression in a wide variety of tissues.
1.2.1 P2X Topology
The molecular structure of the P2X receptor is now established. The subtype 
structures show overlap by 26-47% (North, 2002). They are characterised by two 
transmembrane domains that cross the plasma membrane, linked by a cystine rich 
extracellular loop. The majority of the receptor is extracellular (Brake et al., 1994; 
Valera et al. 1994; Rettinger et al., 2000) with each subunit being between 379 and 
595 amino acids in length. The ATP binding site is contained within this extracellular 
loop (Ennion et al., 2000; Jiang et al., 2000) and it is the site for antagonists and 
modulators (Garcia-Guzman et al., 1997; Clarke et al., 2000). There is a short N- 
terminal and a C-terminal of variable length (see Figure 1.1). Three or four units 
combine to form an ionic pore channel as either homomultimers or heteromultimers 
e.g. P2X2/3 (Lewis et al., 1995). Receptor subtypes have been shown to have variable 
affinities to different agonists and pharmacological profiles have been established 
(Khakh et al., 1999).
Electrophysiological studies have shown that all P2X receptors are cation- 
selective channels. It is thought that Na+ and K+ have almost equal permeability, and 
that Ca2+ also has significant permeability. The influx of calcium through the P2X 
receptors may be important in the physiological functions seen. Calcium has also been
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shown to modulate ATP-evoked currents at expressed P2X receptors (Evans et al., 
1996; Khakh et al., 1999).
1.2.2 P2Y Topology
These receptors are G-protein coupled which are 328-532 amino acids in 
length and have seven transmembrane domains, with an extracellular N-terminus and 
an intracellular C-terminus (Figure 1.2). The conservation between different subtypes 
is greatest in the transmembrane domains with the C-terminus confering the greatest 
diversity between subtypes (Ralevic and Bumstock, 1998). The classification of P2Y 
receptors is less clear than that of P2X receptors with up to 16 heptahelical proteins 
identified that may be associated with the P2Y family, although at present only 8 
subtypes are established in mammals (P2Yi,2 ,4 ,6 ,1 1 ,1 2 ,1 3  a n d  1 4 ) .  The difference has 
occurred because subtypes have been redesignated, such as the p2y3 receptor which is 
regarded as an an orthologue of the P2Y6 receptor, P2 Y59  a n d  1 0  are considered 
‘orphan’ receptors with no functional role and have been removed from the 
classification. The P2Y6 receptor was found to be UTP selective, the P2Y7 receptor 
was reclassified as a leukotrienne receptor, and finally the p2y8 receptor, which was 
cloned from the frog has not had a mammalian counterpart identified, and so is not 
included in the classification (King et al., 2000; Burnstock, 2001b; King and 
Bumstock, 2002).
The P2Y family can be further subdivided into those receptors that couple to 
Gq and consequently activate phospholipase C-P (P2Yi?2,4,6 and 11) and those that 
predominantly couple to G, that inhibit adenyl cyclase and regulate ion channels 
( P 2 Y i 2 , i 3  a n d  1 4 )  (Abbracchio et al., 2003; Lazarowski et al., 2003). A list of tissue 
distribution and functions of P2Y receptors is given in Table 1.1.
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Figure 1.1
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Schematic diagram of a P2X receptor subunit demonstrating 2 transmembrane 
domains (from Brake et al., 1994).
Figure 1.2
intracellular
surface
COOH
Schematic diagram of a P2Y receptor subunit demonstrating 7 transmembrane 
domains (from Barnard et al., 1994).
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1.3 Purinergic transmission and co-transmission
It was observed more than 100 years ago that stimulation of the vagus nerve 
induced relaxation of the stomach, even when the cholinergic component was blocked 
by atropine (Langley, 1898; May, 1904; McSwiney and Robson, 1929). It was 
thought that this relaxation was adrenergic in origin, although it was only blocked by 
adrenergic antagonists at sufficiently high concentrations to inhibit ganglionic 
transmission (Ambache, 1951; Ambache and Edwards, 1951). Later studies 
demonstrated that relaxations and inhibitory junction potentials of guinea-pig taenia 
coli were resistant to both atropine and guanethidine antagonism (Burnstock et al., 
1963; 1964; 1966), but tetrodotoxin (TTX) sensitive (Bulbring and Tomita, 1967), 
confirming that they were nerve-mediated. These observations were the basis of non- 
adrenergic, non-cholinergic (NANC) transmission. At this stage in time “Dale’s 
Principle” dominanted neurotransmission research, with the principle that single 
neurons utilize a single neurotransmitter. It was clear that other neurotransmitters 
were involved, however, confirmation of their identities was elusive. In a classical 
paper in 1970, ATP was shown to be a NANC inhibitory transmitter in the gut, and 
the concept of purinergic nerves and transmission was developed (Burnstock et al., 
1970; Bumstock, 1972).
Evidence for NANC transmission in other tissues was also observed. 
Atropine-resistant contractions of the bladder had been observed in 1895 (Langley 
and Anderson, 1895). Subsequently it was proposed that there was a separate NANC 
innervation of the bladder (Henderson and Roepke, 1934; Chesher and Thorp, 1965; 
Chesher and James, 1966; Ambache and Zar, 1970). Subsequently, these atropine- 
resistant contractions would be shown to be mediated by ATP (Bumstock et al., 
1972a; 1978a; 1978b).
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During this period it became apparent that there were numerous ‘transmission 
systems’ involving transmitters other than ATP, such as glutamate, dopamine, 5- 
hydroxytryptamine (5-HT), as well as a number of peptides. The recognition of 
several neurotransmitters led to a challenge to “Dale’s Principle” of a neuron utilising 
a single neurotransmitter. This longstanding concept was questioned in 1976 in a 
seminal review of the evidence that some nerve fibres synthesise, store and release 
more than one transmitter, with effects induced via postjunctional receptors 
(Bumstock, 1976). This review was the basis of cotransmission from which it has 
become accepted that nerves release multiple neurotransmitters and neuromodulators.
Nerve stimulated contraction of the vas deferens illustrates the story of 
cotransmission whereby excitatory junction potentials (EJPs) were shown to be 
blocked by the sympathetic neurone blocking agents, bretylium and guanethedine, but 
not by the postsynaptic adrenoceptor antagonists prazosin and phentolamine 
(Burnstock and Holman, 1960; 1961). Subsequently, it was shown that ATP induced 
the EJPs and the initial fast phase of the the biphasic contraction of the vas deferens to 
nerve stimulation, with co-released NA inducing the slower, tonic phase of the 
contraction (Sneddon and Westfall, 1983; 1984; Sneddon and Bumstock, 1984).
The expression of purinoceptors in most tissues in conjunction with non­
neuronal release of ATP has led to an explosion of interest in the role of ATP as a 
signalling molecule. Ever increasingly, ATP is being shown to have fast signalling 
and slow trophic and regulatory roles in a wide range of tissues. Key areas of clinical 
interest in purinergic signalling include, pain, nociception, inflammation, bone 
development, anti-neoplastic activity and insulin secretion (Bumstock, 2002). It is 
beyond this thesis to review this topic but excellent reviews are available (Bumstock, 
2003a;b; Bumstock and Knight, 2004).
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1.4 ATP release and metabolism
Inherent with the the demonstration of P2 receptors is that they require ATP as 
a ligand. ATP has been demonstrated in the neuronal vesicles that store NA in 
sympathetic nerves (Langerkrantz, 1976), and also in conjuction with ACh in 
parasympathetic nerves (Hoyes et al., 1975). ATP is therefore released from vesicles 
along with other neurotransmitters following axonal stimulation. The extent of ATP 
release appears to be modulated at a prejunctional level, particularly by adenosine 
(Parija et al., 1991; Palea et al., 1995). Experimentally, the extent of ATP release is 
also affected by the degree of nerve stimulation demonstrating a variable purinergic 
component at differing frequencies (Calvert et al., 2000).
The demonstration of P2 receptors in an ever-increasing range of tissues 
required the demonstration of non-neurogenic release of ATP. Convincing evidence 
for ATP release from vascular endothelial cells and from epithelial cells lining hollow 
viscera on distension and shear stress has now been demonstrated (Figure 1.3), (Bodin 
and Bumstock, 1996; Bumstock, 1999; Vlaskovska et al., 2001; Knight et al., 2002). 
P2X3 receptors have been demonstrated on small diameter sensory neurones and it is 
suggested epithelially-released ATP acts on these receptors during nociception 
(Bumstock, 1999; 2001b).
ATP is rapidly broken down to adenosine and other active metabolites by 
extracellular ecto-ATPases (Zimmermann, 1996; 2001; Burnstock, 1999; Bumstock, 
2001a). These are powerful enzymes, which rapidly metabolise ATP. The efficacy of 
these enzymes is demonstrated by the relatively greater potency of non-hydrolysable 
ATP analogues such as a,P-methylene ATP (a,P-meATP) in organ bath experiments. 
Furthermore, tissue analysis has shown that the ‘bulk phase’ ATP concentration is 
typically much smaller than the cell surface ATP concentration (Lazarowski, 2003).
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The ubiquitous distribution of these enzymes which catalyze nucleotide breakdown 
and interconversion is further evidence for the wider roles of purinergic signalling.
The mechanisms of ATP transport and release from cells is currently much 
debated, and it is thought many tissues such as platelets and secretory cells, utilise 
exocytotic release of specialised vesicular granules which resembles neurotrasmitter 
release. Non-lytic release of ATP is thought to occur in response to mechanical 
stimulation or shear stress from epithlial cells as well as glial cells (see Fig 1.3). 
Furthermore, ATP release from cells may occur in response to pharmacological 
stimuli such as hypoxia or acidosis, or occur without a known stimulus such as the 
secretion of ATP by seminiferous tubules (Gelain et al., 2003).
In addition to vesicular exocytosis other mechanisms for ATP release have 
been suggested, these include ATP binding cassette transporters (ABC), maxi ion 
channels, connexin hemichannels, mitochondrial porins and stretch-activated channels 
(Bodin and Bumstock, 2001; Bumstock, 2003a; Lazarowski et al., 2003).
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Figure 1.3
Smooth muscle
/ / / j .
Subepttheiial 
sensory nerves
Epithelial cells P2X2n receptors DISTENSION
ATP ATP ATP ATP ATP ATP ATPATP ATP ATP ATP
Figure 1.3
Hypothesis that ATP is released from the urothelium o f the ureter on distension and 
acts on P2X3 nociceptors on the suburothelial sensory nerve plexus to relay message 
to the CNS pain centres, (from Burnstock, 1999b).
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1.5 Distribution and function of P2X receptors
A major role of purinergic signalling is in the contraction of smooth muscle, 
however, an ever-increasing distribution of receptors and diversity of function is 
being found (Burnstock and Knight, 2004). The extent of the distribution is given in 
Table 1.1. It would be exhaustive to give a full review but I will highlight key 
receptors, their distribution and function.
P2Xi receptors are localised on smooth muscle cell membranes and are widely 
implicated in normal and pathological smooth muscle contraction.
P2X2 receptors are frequently coexpressed with P2Xi receptors on smooth 
muscle cells, although are often located intracellularly and their function is unclear. 
Recently, they have been demonstrated on interstitial cells of Cajal and may have a 
pacemaker function (Bumstock and Lavin, 2002). They are also found in the CNS and 
autonomic ganglia and commonly form heteromultimers with P2X3 receptors on 
sensory nerve endings.
P2Xj receptors are principally located on sensory neurones, nodose, 
trigeminal and dorsal root ganglia. It is thought they are predominantly involved with 
nociception as indicated by P2X3 receptor deficient mice demonstrating bladder 
hyporeflexia (Cockayne et al., 2000).
P2X* receptors have been located within the CNS and testis, however, their 
function remains elusive. They also form heteromultimers with P2X^ receptors.
P2 X5 receptors have been shown to be associated with cellular differentiation.
P2Xg receptors are slightly unusual in that that they seem unable to form a 
functional homomultimer, but form functional heteromultimers with P2X2 and/or 
P2 X4 receptors. Such heteromultimers have been demonstrated in the CNS.
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P2 X7 receptors have been demonstrated on immune cells and may play a role 
in apoptosis in many other cell types.
Table 1.1
Receptor Main Distribution Transduction Mechanisms
P2X P2Xi
P2X2
P2X3
P2X 4
P2X5
P2X6
P2X7
smooth muscle, platelets, 
cerebellum, dorsal horn spinal 
neurones
smooth muscle, CNS, retina, 
chromaffin cells, autonomic and 
sensory ganglia
sensory neurones, NTS, some 
sympathetic neurones
CNS, testis, colon
proliferating cells in skin, gut, 
bladder, thymus, spinal cord
CNS, motor neurones in spinal 
cord
apoptotic cells in immune cells, 
pancreas, skin etc.
intrinsic cation channel (Ca2+ 
and Na+)
intrinsic ion channel 
(particularly Ca2+)
intrinsic cation channel
intrinsic ion channel 
intrinsic ion channel
intrinsic ion channel
intrinsic cation channel and a 
large pore with prolonged 
activation
P2Y P2Yi
P2Y2
P2Y4
P2Y6
P2Yn
P2Y12
P2Yu
P 2Y i4
Epithelial and endothelial cells, 
platelets, immune cells
Immune cells, epithelial and 
endothelial cells, kidney tubules, 
osteoblasts
Endothelial cells
Some epithelial cells, placenta, T- 
cells, thymus
Spleen, intestine, granulocytes
Platelets, glial cells
Spleen, brain, lymph nodes, bone 
marrow
Placenta, adipose tissue, stomach, 
intestine,discrete brain regions
Gq/Gn; PLCp activation
Gq/Gn and possibly G,; PLCP 
activation
Gq/Gn and possibly Gj; PLCP 
activation
Gq/Gn; PLCP activation
Gq/Gn and Gs; PLCP 
activation
Gi (2); inhibition of adenylate 
cyclase
Gi
Gi/o
Tissue distribution and transduction mechanisms o 
Bumstock, 2003).
purinoceptors (modified from
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1.6 Sperm production, maturation and transport in the 
genito-urinary system
1.6.1.1 Sperm production
The daily spermatozoal production from the human testes is estimated to be 
between 45 and 207 million sperm per day with an average in the order of 100 million 
per day (Freund, 1962; Amann and Howard, 1980). Exact estimates are difficult due 
to variations in the frequency of ejaculation, and the assumption that spermatogenesis 
occurs at a constant rate (Freund, 1963). In comparison to other animals, man has one 
of the lowest daily sperm productions, and human sperm production is estimated at 
4.45 x 106 sperm per gm tissue compared to the rat and the ram, which produce 23.7 
and 19 x 106 sperm per gm tissue respectively. However, the quail produces the most 
recorded at 92 x 106 per gm testis (Amann and Howard, 1980; Clulow and Jones, 
1982). Sperm leaving the testis are immature and lack both forward motility and zona 
pellucida binding capability. These functions develop during their passage through the 
epididymis, however, the extrinsic and intrinsic mechanisms controlling maturation 
are poorly understood. The epididymis contains the majority of the extragonadal 
sperm reserve, being 364 x 106 sperm in man, but this is far greater in other species 
being more than 165000 x 106 sperm in the ram. One consistency between animals is 
that the majority of epididymal sperm is stored in the cauda. In man, 25% is stored in 
the caput, 24% in the corpus and 52% in the cauda, which approximates to other 
animals (Jones, 1999). The proximal vas deferens sperm reserve in man is estimated 
at 18 x 106 and consequently represents less than 5% of the extragonadal reserve. This 
figure is in keeping with other species, which range from 3-15% of total spermatozoa 
storage in the vas deferens (Jones, 1999). Post vasectomy ejaculation studies suggest 
that sperm counts fall to 40% of pre-vasectomy levels within 10 ejaculations
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receptors were also demonstrated on Sertoli cells throughout all stages of 
development. P2Xi and P2 X2 receptors were expressed on blood vessels within the 
testis, but no P2Xi receptors were observed on spermatids (Glass et al., 2001). Sertoli 
cells have been demonstrated to release ATP and adenosine into the extracellular 
medium at a calculated rate of 0.3 and 0.1 nmol/mg protein respectively (Gelain,
2003). To date the physiological function of the expressed P2X receptors remains 
unclear.
1.6.2 Maturation of sperm in the epididymis
1.6.2.1 Structure of epididymis
The epididymis is an internal structure common to all mammals, birds, 
amphibians and some fish (chondrichthyes (sharks and rays)). The common 
anatomical arrangement remains similar across classes. In essence, the seminiferous 
tubules of the testis progressively converge to pass to the rete testis and immediately 
into the ducti efferentes, which converge to become the single convoluted tubule of 
the epididymis. The epididymis length is variable, being approximately 4 metres in 
man (Turner, 1978) and in excess of 40 metres in bovines (Hoskins, 1978). The 
epididymal transit time mirrors this length variation, being between 2 and 16 days 
pending on species and is 4 days in man (Amann et al., 1976; 1980).
The epididymis is divided into 3 histologically distinct regions, the caput, 
corpus and cauda, although a proximal fourth area, the ducti efferentes is usually 
included. In the dog, the ducti efferentes are characterised by short columnar epithelia 
with either cilia or microvilli, which would suggest they are involved with the 
movement of sperm and absorption of testicular fluid. The caput epididymidis is 
characterised by an increased epithelial height, and the presence of stereocilia
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suggesting the ampulla of the vas deferens stores about 40 x 106 sperm (Freund, 
1969).
Spermatids develop from stem spermatogonia at the basal membrane of the 
seminiferous tubules, progressively developing before release into the lumen. In the 
rat this process has been shown to have 14 identifiable stages with germ cell 
development having 19 different steps (Leblond and Clermont, 1952; Hess, 1990). 
These steps are not always seen in man and it is questioned whether all stages occur in 
man. Studies have shown that the human seminiferous tubule has a complex helical 
arrangement, which may explain why tubular cross sections do not show all the 
classical stages of spermatogenesis (Schulze and Rehder, 1984).
Subfertility affects one in 20 men and 15% of couples trying to conceive fail 
to do so within 1 year and are deemed infertile. Male factor infertility is directly 
responsible in 25% of cases and a contributory factor in a further 25%. In 50% of 
cases there is no identifiable cause and any pharmaceutical intervention is empirical 
with no randomised evidence supporting any treatment (Hirsh, 2003; Nicopoullis,
2004). Surgery is appropriate for obstructive cases and hypogonadal causes can be 
treated with hormonal manipulation. Consequently, expensive, invasive and time- 
consuming assisted conception remains the only line of treatment for the vast majority 
of men with male factor infertility.
1.6.1.2 Purinergic signalling and sperm production
The developing rat spermatid, within the testis, has been shown to 
differentially express P2X receptors. P2X2 and P2X3 receptors were demonstrated 
together on developing spermatids in stages I to VIII and were thought to be on the 
developing acrosome. P2X3 receptors were demonstrated in stages X to XIII. P2 X7
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(microvilli with a filamentous core) as well as extensive Golgi activity. 
Micropinocytotic activity was evident at the apical membrane suggestive of an 
absorptive function. The corpus epididymidis was characterised by the presence of 
long stereocilia, often engulfing spermatozoa as well as extensive and organised Golgi 
vesicles. The cauda epididymidis was characterised by a much lower epithelial height 
and the continued presence of stereocilia. There were large numbers of breakdown 
products at the apex of the cells as well as seminal debris within the lumen. There 
were less Golgi vesicles suggesting less active absorption or secretion but prominent 
rough endoplasmic reticulum suggesting greater protein synthesis. The smooth muscle 
cells were arranged in layers, which increased from 2 to 6 layers from the caput to the 
cauda (Chandler et al., 1981).
In summary, the epithelium of the proximal and mid epididymidis is high with 
stereocilia and has a small diameter lumen with minimal surrounding smooth muscle. 
There is a sharp reduction in epithelial thickness with a corresponding increase in 
lumen diameter and smooth muscle coat as the corpus continues into the cauda 
epididymis. The proximal epididymidis has an epithelium suggestive of an absorptive 
and/or secretory function and the distal epididymal epithelium appears less 
functionally active, presumably more appropriate for the storage of mature sperm.
1.6.2.2 Properties of epididymal sperm
Mammalian sperm are immotile when they leave the testis, although can 
develop non-progressive movement if stimulated (Volgmayr et al., 1967). The 
anatomical and ultrastructural characteristics of the epididymis suggest an active role 
in sperm maturation, which is bom out by functional studies on sperm taken from 
different regions of the epididymis. First evidence of this was demonstrated 80 years
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ago, when it was shown that that only 33% of female guinea pigs became pregnant 
when artificially inseminated with sperm obtained from the proximal epididymis, 
whereas 68% became pregnant when inseminated with sperm from the distal 
epididymis (Young, 1929). Early studies suggested that the maturation process was 
intrinsic to the sperm rather than passage through the epididymis, as epididymal 
occlusion studies demonstrated increased fertilisation rates from sperm prevented 
from leaving the proximal epididymis (Young, 1931). Human studies involving 
fertility rates following epididymo-vasostomy suggest that only passage through the 
caput epididymis is required for fertility, although the success rate increased with 
more distal anastomoses (Schoysman, 1986). These studies must be interpreted with 
caution, as by definition they involve abnormal epididymis, and, as the anastomosis is 
proximal to the obstruction there may be a degree of reflux of epithelial fluids from 
downstream of the anastomosis. Spermatozoa may be motile as they have been 
exposed to distal maturing factors, despite their anatomically proximal position 
(Cooper, 1990). This is supported by the demonstration of forward motility and IVF 
potential in sperm taken from the caput epididymis from men with vas deferens 
agenesis but not from anatomically normal controls in whom motility was only 
observed in sperm from the corpus epididymis (Mathieu, 1992). In normal 
epididymides, it was found that 22.9% of sperm from the caput/corpus junction were 
motile in comparison to 68.3% from the mid to distal corpus with a slight reduction in 
the cauda (Yeung, 1993). Human micro-canulation studies suggest that the 
development of motility appears suddenly at the junction of the distal caput and 
proximal corpus epididymis (Dacheux, 1992). Similarly, it has been demonstrated that 
the ability of human epididymal sperm to bind to zona-free hamster oocytes increased
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with successive epididymal segments, and that only sperm from the cauda epididymis 
were able to penetrate the oocyte (Hinrichsen, 1980).
1.6.2.3 Membrane changes in epididymal sperm
Immature sperm entering the caput epididymis continue the process of 
spermiation and are morphologically different from those of the cauda although these 
observations are least distinct in man. The most obvious change is migration and loss 
of the cytoplasmic droplet. In testicular sperm this droplet is located at the anterior 
midpiece but migrates to the more distal annular region before dissociating 
completely by the time the spermatozoa reaches the cauda epididymis. The acrosome 
undergoes significant remodelling during the transit through the epididymis. It is 
thought that the development of spermatozoa in the testis is under the genomic 
regulation of the gamete, but once DNA condensation has occurred in elongated 
spermatids, the transcription process in the germinal DNA stops (Dacheux, 1998). It 
is thought the external milieu surrounding the gamete is responsible for further 
differentiation. It is the content and interaction of the the spermatozoa with the 
epididymal fluid, as well as spermatozoa interaction with the epididymal epithelium 
that is responsible for further spermatid development. Over 200 proteins have been 
identified in epididymal fluid, although most are secreted in very small amounts and 
gel electrophoresis suggests that 10 proteins make up 90%, and 2 proteins 52% of 
secreted protein. The pattern of protein secretion is specific to different regions of the 
epididymis. The epididymal secretions responsible for specific sperm modification 
appear to be discrete unidentified proteins (Dacheux, 1998).
The sperm membrane has an unusually high proportion of polyunsaturated 
phospholipids which give it special characteristics, furthermore, within the membrane
39
component proteins and lipids are compartmentalized into discrete domains on the 
head and tail. During maturation, the plasma membrane undergoes remodelling by the 
uptake of secreted glycoproteins, removal and utilization of phospholipids from the 
inner leaflet of the bilayer, and processing of existent glycoproteins (Jones, 1998). 
The ionic content of epididymal fluid is low which would allow most proteins to be in 
contact with the cell membrane (Jones, 1978). Changes in the charge on the cell 
membrane may facilitate the insertion of secreted integral membrane proteins. 
Changes in the charged integral proteins may lead to compartmentalization into a 
mosaic of specific domains. This may also be induced by the sterol content of the 
membrane, which in turn may be affected by the many lipid-binding proteins secreted 
by the epididymal epithelium. (Cooper, 1998). The sperm membrane is rich in 
glycoproteins, which are thought to be essential in the recognition and binding to the 
zona pellucida. The epididymal fluid is rich in both glycosyltransferases (synthetic) 
and glycosidases (hydrolytic), which have been demonstrated to modify sperm 
membrane glycoproteins during epididymal transit (Tulsiani, 1998).
1.6.2.4 Capacitation and the acrosome reaction
In order for a sperm to achieve successful fertilization of an egg, it must firstly 
undergo capacitation, which occurs in the female genital tract during the phase 
between ejaculation and fertilization. It involves a series of incompletely understood 
cellular and molecular alterations, which enable the spermatozoa to subsequently 
undergo the acrosome reaction immediately prior to fertilization. Modification and 
induction of capacitation may occur as a result of interaction with, or incorporation of 
proteins in fluid from both the male and female genital tracts. Proteins or molecules 
from within the spermatozoa itself may also be released for integration with the
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membrane. Spermatozoa become coated with proteins as these pass through the 
epididymis, which may inhibit capacitation and prevent the acrosome reaction 
occurring prematurely. These proteins may stabilise the membrane and possibly block 
receptors (Mbivzo and Alexander, 1991; Rajalakshmi and Griffin, 1999). This process 
is reversible as capacitated sperm can be decapacitated by the supematatant from 
centrifuged semen (Fraser, 1990). Capacitation is characterised by increased 
membrane fluidity, a decrease in plasma membrane cholesterol to phospholipid ratio, 
a reduction in surface charge, and an increase in cAMP and oxidative processes in 
conjunction with a change in swimming patterns (Guraya, 2000). The resultant 
membrane change may facilitate Ca2+ entry, which then chelates anionic phospholipid 
molecules and promotes fusion between the plasma membrane and outer acrosomal 
membrane (Mbivzo and Alexander, 1991; Cross, 1998). The precise trigger for 
capacitation is unidentified, and may not be a single agent as numerous media are able 
to induce capacitation and the acrosome reaction in vitro. One of the simplest 
stimulants used is serum and particularly albumin or the macromolecules associated 
with albumin (Guraya, 2000).
The acrosome reaction involves point fusions between the outer acrosomal 
membrane and the overlying plasmalemma. Calcium alone is required for this 
reaction to occur, providing capacitation is complete. The acrosome reaction results in 
the release of hydrolytic enzymes from the acrosome and the generation of greater 
thrust and hyperactivity to facilitate penetration of the of the egg investments by the 
spermatozoa. There is no clear biochemical marker for completion of the acrosome 
reaction.
ATP may have an important role in the acrosome reaction, as ATP rapidly 
induced the acrosome reaction in a Ca 2+ independent manner, probably through the
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activation of Na+ channels, and ATP-activated sperm from patients with male factor 
infertility had a significantly higher fertilisation rate (Foresta et al., 1992; 1996; 
Rossato et al., 1999). Sperm in the cauda epididymis have been shown to have an 
ecto-ATPase present on the cell membrane which potentially maintains inactivity in 
the epididymis by hydrolysis of ATP (Majunder and Biswas, 1979).
1.6.2.5 Sperm motilty and ATP
The microscopic arrangement of mitochondria around the midpiece of sperm 
implies significant synthesis and utilisation of ATP for rapid swimming. Seminal fluid 
has a relatively high ATP content, which is generally viewed as an energy substrate 
(Singer et al., 1983). The presence of ATP in semen suggests a limited substrate or 
fuel source, that when consumed results in sperm immotility or death. It has been 
suggested that reduced seminal ATP levels are implicated in infertility, however, 
investigative studies have failed to find a correlation between seminal ATP and 
infertility (Irvine and Aitken, 1985; Mieussetet al., 1989; Vigue et al., 1992; WHO, 
1992). This may be explained by the fact that sperm synthesise ATP, and so seminal 
fluid ATP is not the only ATP source. Quiescent rat sperm from the cauda epididymis 
were found to have a very high ATP content of about 100 mM/108 spermatozoa, 
which had presumably accumulated during epididymal transit. When sperm were 
placed into a substrate (acetate, lactate, pyruvate and glucose) containing medium 
they immediately became motile and the ATP content rapidly fell to a steady state of 
50mM/108 spermatozoa, which was maintained for at least 2 hours. In the absence of 
substrates sperm motility reduced rapidly after 90 minutes. The pattern of sperm 
motility was significantly dependent on the presence of substrates. Initial head 
rotation was observed to be 2.3 rotations /second, straight-line velocity was 105 pM/s
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and flagella beat frequency was approximately 10Hz. After 120 minutes without 
substrates all parameters were significantly reduced and only 18% of spermatozoa 
were still progressively motile. These parameters were reversible on the addition of 
substrates (Jeulin and Soufir, 1992). It has been postulated that the very high ATP 
content of caudal epididymal sperm may actually inhibit ATP induced microtubule 
sliding and mitochondrial activity in order to maintain the spermatozoa in a quiescent 
state (Ishijima and Witman, 1987; Jeulin and Soufir, 1992).
1.7 Movement of sperm from the seminiferous tubules
The basic mechanism by which sperm undergo expulsion from the 
seminiferous tubules of the testis into the rete testis and pass through the epididymis 
and vas deferens is poorly understood. It is postulated that sperm move out of the 
seminiferous tubules due to peristaltic forces of the seminiferous tubules themselves, 
an effluent tide of fluid produced by the seminiferous tubules, the movement of cilia 
on the epithelium of the rete testis and finally contractions of the tunica albuginea of 
the testis (Hargrove et al., 1977). Evidence for cilia-induced movement is limited 
with calculations suggesting inadequate numbers of cilia for estimated flux and the 
presence of normal numbers of sperm in the epididymis in patients with Kartageners 
syndrome in which cilia are immotile (Winet, 1977; Afzelius, 1976). The effluent tide 
is significant, with the testes of boars producing 40 mis of fluid a day of which only 1 
ml leaves the epididymis (Setchell, 1970). There are myoid cells, usually only 1 cell 
thick surrounding the seminiferous tubules and despite an absence of innervation, 
these have been shown to contract to noradrenaline (NA), acetylcholine (ACh), 
oxytocin, endothelin and prostaglandins (Ellis et al., 1977; Miyakye et al., 1986;
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Barone et al., 2002). The functional significance of these contractions is unknown and 
there are no reports of contractions to purinergic agonists.
Smooth muscle contraction of the rabbit tunica albuginea was first shown in 
1967 (Holstein, 1967), and contractions of the rat tunica albuginea to NA and ACh 
were demonstrated in 1969 (Davis and Langford, 1969). Smooth muscle has been 
demonstrated in the human, rat, rabbit, cat, dog, sheep, pig, cow and horse testicular 
capsules (Davis, 1969; 1970; Langford, 1973; Leeson, 1974; Ohanian et al., 1979; 
Chacon-Arellano et al., 1980). The extent and organisation of the smooth muscle 
varies between species and only in the rabbit does an organised muscle layer appear to 
exist, and indeed two layers perpendicular to each other are reported (Davis, 1970). In 
most other species examined, including man, no distinct muscle layer is present and 
no neuronal innervation demonstrated, although more recently Middendorf has 
claimed that there is a distinct inner smooth muscle layer (Middendorf et al., 2002). 
Developmental studies suggest that the smooth muscle develops postnatally at the 
time of sexual maturity (Leeson, 1981; Holt et al., 2004). The mechanisms controlling 
muscular contraction and propulsion are varied, but NA, ACh, oxytocin, 
prostaglandins and gonadal hormones have all been implicated (Davis and Langford, 
1969; Hargrove et al., 1972; Seeley, 1972; Sanchez, 1991). Spontaneous contractions 
have been demonstrated in man, rabbits and rats. Contractions have typically been 
monophasic and slow (Davis et al., 1970). It is unknown whether contractions are 
continuous or occur in response to stimulation or ejaculation. To date no contraction 
to purinergic agonists has been reported, and contraction of the mouse tunica 
albuginea has not been demonstrated.
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1.8 Purinergic co-transmission in the contraction of vas 
deferens smooth muscle
NA and ATP have been shown to mediate contraction of the rat and guinea pig 
vas deferens smooth muscle. The contraction, in response to electrical field 
stimulation (EFS) of sympathetic nerves has been shown to be biphasic (Fedan et al., 
1981; Meldrum and Bumstock, 1983; Sneddon et al., 1984). ATP, released from 
sympathetic nerves, acts through ion-gated P2X receptors to stimulate the initial fast 
phase of the contraction, with co-released NA causing the more sustained, but slower 
contraction, acting through G protein-coupled a  adrenoceptors. P2Xi receptors have 
been demonstrated on vas deferens smooth muscle membranes, with one report 
suggesting expression on all 3 muscle layers and another suggesting expression on 
only the outer 2 layers, and not the inner layer (Lee et al., 2000a; Mulryan et al., 
2000). Functional importance of P2Xi receptors in contraction of the vas deferens was 
shown by the demonstration that P2Xj receptor null mice had a 90% reduction in 
fertility, despite fertile sperm. The infertility was due to reduced nerve-induced 
contractions of the vas deferens smooth muscle. The smooth muscle was still 
contractile in response to NA, but resulting ejaculates had insufficient sperm for 
fertilisation. This study suggested that notional P2Xi receptor antagonists could be 
successful in male contraception, despite a complete absence of knowledge of either 
the expression or function of P2Xi receptors in human vas deferens (Mulryan et al., 
2000).
Contraction of the human vas deferens smooth muscle is reported to be purely 
adrenergic stimulation, although modified by numerous substances (Anton and 
McGrath, 1977; Steers, 1994). Human nerve-induced responses are reported to be
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about 10 times slower than those of the rat. Twitch responses to single shocks have 
been found to be TTX insensitive, but electrical-induced tetanic responses have been 
shown to be sensitive to prazosin and TTX, although up to 23% of the original 
response persists. Some sections of human vas deferens have been shown to relax in 
response to low voltage (40V) EFS, which was atropine sensitive. Higher voltages 
(90V) induced contractions with a time to peak of 3-7 S. Exogenous NA caused tonic 
contractions, induced spontaneous contractions and potentiated the response to 
electrical stimulation. Some short segments of human vas deferens relaxed in 
response to NA, which was explained by contraction of the circular smooth muscle. 
Adenosine and ATP were found to inhibit the EFS induced responses by about 30%, 
however inhibition was variable (Pryor and Smith, 1986; Smith and Bray, 1990). To 
date there are no studies into purinergic co-transmission or P2X receptor expression in 
human vas deferens.
1.9 Purinergic signalling in the bladder
1.9.1 Normal bladder physiology
The primary function of the bladder is low pressure urinary storage with 
periodic voluntary emptying. Failure of normal bladder function can be very 
debilitating and represents a huge socio-economic health problem. Normal bladder 
function involves progressive relaxation of the detrusor as it fills, whilst maintaining 
continence by contraction of the urinary sphincter. During voiding, the reverse occurs 
with sphincter relaxation and coordinated detrusor contraction. The autonomic 
nervous system is integral to both detrusor and sphincter components. Normal 
detrusor contraction is mediated by the release of ACh from parasympathetic nerves 
acting on G-protein coupled muscarinic (M) receptors to cause smooth muscle
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contraction. Sympathetic neurons help maintain continence through ai adrenergic 
receptors at the bladder neck and somatic nerves innervate the voluntary external 
sphincter. Several muscarinic receptors are expressed and despite the predominance 
of M2 receptor expression, it appears the M3 receptor subtype is functionally most 
important (Wang et al., 1995; Chappie et al., 2002). In man atropine almost 
completely antagonises nerve-mediated detrusor contraction (Bayliss et al., 1999). 
The situation in animals is different, and over 100 years ago atropine was shown to 
incompletely inhibit bladder contraction, leaving a significant NANC component 
(Langley and Anderson, 1895). ATP was shown to mimic tetanic nerve stimulation, 
which was antagonised by quinidine and tachyphylaxis to ATP reduced nerve- 
mediated responses. The demonstration of excitatory junction potentials due to the 
neurogenic release of ATP in the bladder has been integral to purinergic co­
transmission (Bumstock et al., 1972; Moss and Bumstock, 1985; Burnstock, 2001). 
Despite the lack of purinergic function in normal human detrusor, as assessed by 
antagonism of nerve stimulated responses, isolated strips of bladder demonstrate 
concentration-dependent contractions to a,P-me ATP, smooth muscle cells generate 
inward currents in response to ATP, and mRNA for P2X 1 ,2 ,4 ,5  a n d  7  receptor subtypes 
is detectable (Hoyle et al., 1989; Inoue and Brading, 1991; Palea et al., 1995; O’Reilly 
et al., 2002). P2Xi receptors are expressed on the smooth muscle membranes of rat 
detrusor and non-membrane-bound P2 X2,5 and 6 receptors are also expressed in the 
bladder (Lee et al., 2000a; Vial and Evans, 2001). The detrusor smooth muscle from 
P2Xi receptor deficient mice showed no inward current in response to purinergic 
agonists confirming that the P2Xi receptor subtype is responsible for purinergic EJPs. 
There was no compensatory change in either the myogenic or cholinergic 
components, and the bladders appeared morphologically and functionally normal
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(Vial and Evans, 2000). In awake rats undergoing cystometry, intra arterial 
administration of ATP and a,P-meATP close to the bladder caused rapid pressure 
rises and immediate micturition. Pre-treatment with a,P-meATP caused a subsequent 
reduction in micturition pressures and increased bladder capacity. Similarly, 
carbachol (CCH) caused rapid sustained pressure rises leading to micturition and 
spontaneous contractions continued after treatment with atropine. The combination of 
atropine and pre-treatment with a,P-meATP resulted in retention and dribbling 
incontinence (Igawa et al., 1993). This would suggest that both systems are 
functionally important in normal rat micturition.
1.9.2 Purinergic signalling in the pathophysiology of the overactive 
bladder
In the UK, it is estimated 9 million people over 40 years old are affected by 
urinary storage symptoms and 5 million require healthcare (McGrowther, 2004). 
Bladder overactivity is thought to be the cause in one third of female sufferers, and up 
to half of male sufferers. The condition of bladder overactivity is characterised by 
involuntary bladder contractions causing pressure rises during bladder filling, which 
result in a strong and uncontrollable urge to pass urine, which often leads to 
incontinence (Abrams et al., 1990). Prevalence increases with age and deteriorating 
health and it is twice as common in females as males. Presentation in women is most 
common in the 2nd to 4th decade (Thakar, 2000). There is significant associated 
morbidity in terms of increased falls or fractures, and it increases the risk of 
admission to hospital or nursing care (Thom et al., 1997; Brown et al., 2000).
The natural history of bladder overactivity is incompletely understood, 
however, in a subset of men it is thought to develop secondarily to progressive
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bladder outflow obstruction (BOO). BOO is a common condition in the older male, 
usually resulting from benign prostatic hyperplasia (BPH). Nearly 50% of all men 
aged 60-69 suffer from symptoms of BPH (Garraway et al., 1991). BPH is 
histologically evident in up to 88% of prostates obtained at post mortem from patients 
aged over 80 years (Napalkov et al., 1995). Symptoms can arise from the physical 
obstruction to flow, such as hesitancy and reduced urinary stream, or from secondary 
damage to the detrusor muscle resulting in storage difficulties. This can manifest as 
detrusor overactivity, with symptoms of frequency, urgency and urge incontinence. 
Studies have shown that 50-75% of men with BOO due to BPH develop detrusor 
overactivity, but 62% will revert to normal cystometry following prostatectomy 
(Abrams et al., 1979; 1985). However, 19% of patients will continue to have 
symptoms of bladder overactivity post surgery (Gormley, 1993; Thomas and Abrams, 
2000), and a large proportion of patients who had their overactivity reversed by 
prostatectomy will subsequently return to overactivity in the long-term (Leach et al., 
1996). The mainstay of pharmacological management of detrusor overactivity are 
anti-cholinergic agents, of which oxybutynin is the most established. Studies have 
suggested that the frequency of micturition can be decreased by oxybutynin in 20 % 
of patients, versus 10% with placebo (Appell, 1997) and incontinence episodes 
reduced by 71% versus 19 % with placebo (Abrams et al., 1998). A Cochrane review 
collating 32 studies and 6800 people suggested that anticholinergic treatment reduced 
the number of micturitions in 24 hours by 2.5, however placebo reduced the number 
by 1.6 (Herbison, 2003). The incidence of anti-muscarinic side effects remains very 
high with 57-93% of patients experiencing some, and 23 % of patients stopping 
treatment as a result (Moisey et al., 1990; Appell, 1997). Long-term data is deficient, 
but it would seem that treatment is unsatisfactory. With surgical treatments reserved
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for only intractable cases of bladder overactivity, the pharmaceutical market remains 
huge, grossing an estimated $6.11 billion per year (Madersbacher, 2005). 
Consequently, novel therapeutic targets offer exciting prospects.
Two main theories have been suggested as to the cause of detrusor 
overactivity, principally a myogenic cause, in which the smooth muscle excitability 
and electrical coupling are intrinsically altered, and a neurogenic cause, in which there 
is up or down regulation of the neuronal mechanisms responsible for detrusor 
contraction. The mainstay of the myogenic theory is that the spontaneous contractions 
that characterise detrusor overactivity are TTX resistant, and structural changes are 
evident at electron microscopic level (Brading, 1997; Elbadawi et al., 1993). The 
neurogenic theory suggests that peripheral or central pathways are altered, possibly 
from reduced central inhibition, enhancement of local pathways, increased afferent 
input from lower urinary tract or the development of resistant local bladder reflexes 
(De Groat, 1997).
These theories are not incompatible with each other as detrusor overactivity 
represents a spectrum of disease, depending on the underlying pathological cause, and 
the development of the condition. The human detrusor adapts to bladder outflow 
obstruction and undergoes a progression from initial hypertrophy, resulting in 
compensation, to a decompensation phase which results in either a small, fibrotic, low 
capacity, poorly compliant overactive bladder, or a grossly dilated, thin, high capacity 
bladder. It is therefore not surprising that a unified theory does not exist, as different 
theories may apply in different pathological settings. Animal models may imitate a 
particular phase or point on a progressive pathology.
A number of studies have suggested that the purinergic component of human 
bladder contraction is up-regulated in the pathological state. In the normal human
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bladder the purinergic component of detrusor contraction is probably less than 5%, as 
atropine completely antagonises field stimulation responses (Bayliss et al., 1999). In 
the pathological human bladder the purinergic component accounted for 40 % of the 
contraction in interstitial cystitis, up to 50 % in idiopathic female detrusor instability, 
and in cases of proven bladder instability, significant up-regulation was demonstrated 
(Palea et al., 1983; Bayliss et al., 1999; O’Reilly et al., 2002). The purinergic 
component of human bladder contraction has been shown to be increased and the 
cholinergic component reduced with age (Yoshida et al., 2001). Other studies 
contradict this, suggesting that the purinergic component as assessed by antagonism is 
5% in overactivity and 3% in controls, with a significant up-regulation of the 
myogenic or TTX resistant component (Mills et al., 2000).
The up-regulation of the purinergic component cannot be explained by altered 
sensitivity, as detrusor myocytes from stable and unstable bladders were equally 
sensitive to cholinergic and purinergic agonists (Wu et al., 1999). A reduction in ecto- 
ATPase enzyme activity has been demonstrated from unstable or obstructed bladders, 
and this may account for increased potency of ATP in these pathological states 
(Harvey et al., 2002). Increased expression of the P2X receptors has also been 
suggested, but only increased P2X2 receptor expression has been demonstrated in 
detrusor overactivity (O’Reilly et al., 2002). The function of the P2X2 receptor in 
smooth muscle contraction has yet to be elucidated.
Animal models of bladder outflow obstruction have demonstrated that bladder 
instability occurs following obstruction (Malmgren et al., 1987; Igawa et al., 1993; 
O’Connor et al., 1997; Lluel et al., 1998). A number of animal models have 
demonstrated changes in the purinergic and cholinergic components of detrusor 
neurogenic contractions. Findings are variable and probably represent species
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differences, as well as variations in the degree and duration of bladder obstruction. 
For instance, Sjuve found that sensitivity to purinergic receptor agonists was reduced 
following 10 days of obstruction in a rat model (Sjuve et al., 1995). In a long-term rat 
obstruction model, Lluel found only the cholinergic element of EFS-induced detrusor 
contractions to be increased (Lluel et al., 2002). In contrast, Calvert found that the 
purinergic component of EFS bladder contraction in a rabbit following 3 weeks of 
obstruction was increased, with a reduction in the cholinergic component (Calvert et 
al., 2001). Animal models of bladder outlet obstruction must be interpreted with 
caution as they may represent the response to acute retention and subsequent detrusor 
failure, as indicated by bladder weight increases of several hundred percent and 
reduced contractile responses to potassium chloride (KC1).
In the present study, the effect of partial bladder outlet obstruction on the 
contraction of the detrusor in the rat was investigated. The hypothesis that up- 
regulation of the purinergic component occurred in response to bladder outlet 
obstruction was tested.
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CHAPTER 2
GENERAL METHODS
2.1 Organ-bath pharmacological studies
2.1.1 Apparatus
Glass organ-baths of 10ml capacity were used for all pharmacological 
experiments. Experiments were performed at temperatures that most approximated to 
their in vivo situation. Therefore, testes and vas deferens studies were carried out at 
35° +/- 1° C to approximate to scrotal body temperature, and bladder studies at 37° 
+/- 1° C for bladder temperature. All experiments were carried out in Krebs solution 
continually gassed with a mixture of 95 % O2 and 5 % CO2.
Depending on the tissue size, either whole preparations, or strips of tissue 
were used. 3’0  silk ligatures were attached to each end of the preparation. One end of 
the specimen was fixed to a rigid support and the other end was attached to a force 
displacement transducer (Grass FTOC3, Quincy, MA, USA). For Electrical Field 
Stimulation (EFS) studies, the support was modified to incorporate two platinum ring 
electrodes 2.5mm in diameter and placed vertically 1 cm apart. The tissue preparation 
was threaded through these ring electrodes. Isometric contractions were recorded 
using the software PowerLab Chart for Windows (version 4; AD Instruments, 
Australia).
EFS was produced by an electrical stimulator (Grass, Quincy, MA, USA). 
EFS parameters were 100 V, 0.3-0.5 ms, 0.5-64 Hz, for 15-60s every 3-5 min. The 
exact parameters were optimised for each tissue type, and subsequently maintained 
for that tissue.
An initial load of between 0.2 -1.0 g was applied to the preparations, following 
their set up. The Krebs solution in the organ bath was then changed and the initial 
load readjusted. No subsequent load adjustments were made despite universal
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relaxation of the specimens. All tissue preparations were allowed to equilibrate for at 
least 45 minutes prior to start of experimentation.
2.1.2 Animals
Mice, rats, hamsters and rabbits were supplied by UCL animal laboratories 
and were kept in accordance with Home Office (UK) regulations. Mice, rats and 
hamsters were sacrificed according to Home Office (UK) regulations covering 
Schedule 1 procedures -following CO2 asphyxiation and cervical dislocation. Rabbits 
were sacrificed following terminal anaesthetic, followed by cervical dislocation in 
accordance with Schedule 1 procedures. The number of animals sacrificed was 
minimalised by obtaining genital tissue from animals being sacrificed for different 
studies.
2.1.3 Tissue Preparation for Organ-Bath Studies
All tissues were collected into Krebs solution, and subsequent preparation was 
performed as rapidly as possible. Tissues were pinned into wax-based petri dishes 
containing Krebs solution and prepared under an operating microscope.
2.1.3.1 Testicular capsule tissue
The testis, epididymis and vas deferens were removed en bloc following a 
scrotal-pelvic incision. The preparation was placed immediately into Krebs solution. 
Subsequently the epididymis and vas deferens were removed and residual fat was 
cleaned from the testis.
For rat and mouse tissue, a small incision was made parallel to the long axis of 
the testis in the anterior (i.e. opposite rete testis) border of the testis. The testis capsule
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was then everted extruding the seminiferous tubules. The seminiferous tubules were 
only adherent to the capsule at the vascular/epididymal hilum of the testis. This 
attachment was divided and the capsule was returned to its original orientation. Silk 
ligatures were then attached to the two polar regions of the whole capsule or tunica 
albuginea preparation. Rabbit testes were relatively larger and so strips of tunica 
albuginea approximately 2  x 2 0 mm were cut in the capsule and freed of underlying 
seminiferous tubules.
Ethical approval was obtained from the hospital ethical committee. Human 
testes were taken from patients undergoing an orchidectomy for either gender 
reassignment, or for the treatment of prostatic carcinoma. Individual consent was 
obtained from all patients, who were frilly informed of the type of experiment their 
tissue would be used for and subsequent storage. Each patient was given an 
information sheet and a copy of their consent form. Whole capsule preparations were 
not feasible, therefore a patch of tunica albuginea was taken from the mid portion of 
the testis near the rete testis. This area was chosen because reported histological 
studies suggested a greater concentration of smooth muscle fibres near the rete testis. 
Each patch was then cut longitudinally into strips approximately 2 x 20 mm. These 
could then be mounted in a similar way to the whole capsule preparations of the 
mouse and rat. The seminiferous tubules were more adherent in man and some septae 
extended into the body of the testis from the capsule.
2.1.3.2 Human vas deferens tissue
Human vas deferens specimens were taken from patients undergoing a 
vasectomy for sterility or orchidectomy for either testicular or prostatic carcinoma. 
All patients gave consent and the hospital ethics committee approved the study.
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Specimens were collected directly into Krebs solution. Each specimen was divided 
longitudinally into quarters to give specimens approximately 2 x 20 mm in size. This 
was for four reasons: the first being to minimise diffusion distances, the second to 
allow all three muscle layers exposure to agonists and antagonists, the third to allow 
the specimen to be used in the available apparatus and the fourth was to allow 
multiple studies on a small vas deferens specimen. Whole specimens were tried, but 
offered no obvious advantage. The specimens were mounted longitudinally. Vas 
deferens specimens from orchidectomy patients were taken from the scrotal vas 
deferens approximately 4 cm from the epididymis so that they would be comparable 
to the vasectomy vas deferens specimens.
Two sets of EFS were carried out on human tissue. Initial stimulations were 
often variable and inconsistent but second stimulations were much more consistent 
and these were used for investigation. An initial load of 1 g was applied.
2.1.3.3 Obstructed rat bladder tissue
Female rats, which had undergone partial bladder outlet obstruction or sham 
operation (see chapter 6 ), were killed following CO2 asphyxiation and cervical 
dislocation. The bladders were exposed via a lower abdominal midline incision. In the 
obstructed rats the bladder was significantly larger and the peritoneum overlying the 
dome of the bladder was usually thickened and more adherent to the bladder. The 
peritoneum was dissected off the bladder, the ureters divided and the urethra excised 
just distal to the bladder neck. The bladder was then excised and placed into Krebs 
solution. The bladder was weighed as a total specimen. The bladder neck was excised 
at the level of the ureters. The detrusor was then incised longitudinally to the dome. 
Subsequently, longitudinal strips measuring approximately 2 x 20 mm were cut and
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mounted as previously described. For the bladder studies, the organ bath Krebs 
solution was modified to include indomethacin (1 jiM). Initial pilot studies showed 
that the obstructed bladder preparations demonstrated marked spontaneous smooth 
muscle activity, therefore, indomethacin was added to reduce this. An initial load of 1 
g was applied.
2.2 Presentation of data and statistical analysis
2.2 1 Agonists
Wherever possible full concentration-response curves were constructed and 
EC50 values calculated. Concentration-response curves to ACh were constructed with 
cumulative applications. Those to NA, ATP, a,|3-MeATP and P,y-methylene ATP (Py 
ATP) were applied in single boluses. The reason for this was that preparations were 
prone to desensitise, particularly with purinergic agonists. Consequently, single dose 
administration, with immediate washout on achieving maximal response was utilised. 
Furthermore, wherever possible, different agonists were applied alternatively to allow 
tissues greater recovery time. At the end of each experiment a standard dose of 120 
mM KC1 was added to the organ bath to determine a response. To allow for 
differences in specimen size, concentration-response curves were expressed as a mean 
% of the KC1 response obtained for any preparation ± standard error of the mean (s.e.) 
for the number of animals used (n).
For relaxation responses of the mouse testicular capsule, an initial contraction 
was applied to the preparation by pre-contracting it with ACh at its E C 5 0  
concentration. Subsequent relaxation responses to NA were examined in a cumulative 
manner and expressed as the mean % relaxation ± s.e. (n).
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2.2.2 Antagonists and desensitisation
Potential antagonists were introduced to the organ bath preparations at least 20 min 
prior to repeat EFS. Responses were expressed as either the % of the KC1 response, or 
as the % of the maximum response in the absence of antagonists. Desensitisation of 
the P2X receptors was achieved by adding 2 or 3 100 pM boluses of a,p-MeATP, 5- 
10 min apart which were not washed out. Desensitisation was confirmed by an absent 
response to a single bolus of 100 pM ATP.
2.2.3 Statistical analysis
Statistical analysis was carried out using GraphPad Prism (GraphPad 
Software, Inc., San Diego, CA, USA).To test if the frequency-response and 
concentration-response curves were significantly different from each other statistical 
significance was tested by a 2-way analysis of variance (ANOVA), followed by 
Bonferroni’s test. A probability of P  < 0.05 was considered significant.
2.3 Physiological salines
Modified Krebs solution of the following composition was used in all organ 
bath studies; (mM): NaCl, 133; KC1, 4.7; NaHC03, 16.4; MgS04, 0.6; NaH2P0 4 , 1.4; 
glucose, 7.7 and CaCl2, 2.5; pH 7.3. In studies on the obstructed rat bladder 
indomethacin 3pM was added to the Krebs solution.
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2.4 Immunohistochemistry
2.4.1 Preparation of tissue for immunohistochemistry
Tissue samples were collected in Krebs solution, then embedded in Tissue Tek 
OCT compound (Sakura, Zoederwoude, Netherlands) and snap-frozen in isopentane 
pre-cooled in liquid nitrogen. Tissues were sectioned at 12 pm using a cryostat (Leica 
CM 3050, Nussloch, Switzerland), sections were then thaw mounted on gelatin- 
coated slides and air-dried at room temperature. The slides were stored at -20°C and 
allowed to return to room temperature for at least 10 min prior to use.
2.4.2 Immunohistochemistry protocol
The avidin-biotin technique was used, as described by Llewellyn-Smith et al 
(Llewellyn-Smith, 1992; 1993). Briefly, the slides were fixed in 4% formaldehyde 
and 0.2% of a saturated picric acid solution in 0.1 M phosphate buffer for 2 min. To 
inactivate endogenous peroxidase, the sections were then treated with 50% methanol 
containing 0.4 % hydrogen peroxide for 10 min. Non-specific binding sites were 
blocked by incubating with 10 % normal horse serum (NHS) in phosphate buffered 
saline containing 0.05 % thimerosal (Merthiolate) for 20 minutes. The P2X antibodies 
were diluted to 0.25-5 pg/ml (determined by prior titration) with normal horse serum 
and the sections were incubated with primary antibodies overnight at room 
temperature. They were subsequently incubated with a secondary antibody which was 
a biotinylated donkey anti-rabbit IgG (Jackson Immunoresearch, Luton, UK) used at 
1:500 for lhr. Sections underwent a further incubation with extravidin peroxidase 
(Sigma Chemical Co, Poole, UK) at 1:1000 for 1 hr. The reaction product was 
visualised using the nickel-intensified diaminobenzide (DAB) enhancement technique
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or using streptavidin fluoroscein isothiocyanate (FITC) immunofluorescence. The 
specimens were dehydrated in xylene and mounted in Eukitt (BDH). Controls were 
performed with pre-immune IgG and antibodies pre-adsorbed with the homologous 
peptides and omission of the primary antibody; minimal staining was observed under 
such conditions.
2.4.3 Antibodies
The immunogens used were peptides corresponding to 15 receptor type 
specific amino acids in the C-terminal region of the receptor. The synthetic peptides 
were covalently linked to limpet haemocyanin and the conjugate was administered to 
rabbits at monthly intervals (performed by Research Genetics, Huntsville, Ala., USA). 
Immunoglobulin G (IgG) fractions were isolated from the immune and pre-immune 
sera for the seven P2X receptor subtypes, using the method of Harboe and Ingild 
(Harboe and Ingild, 1973). The specificity of the antibodies was verified by 
immunoblotting as previously described (Oglesby et al., 1999). Peanut agglutinin 
antibodies were used for identification of the spermatid acrosome.
2.4.4 Microscopy and photography
The results were documented using the Edge R400 high definition light 
microscope (Edge Scientific Instruments, Santa Monica, CA). Pictures were stored 
using digital camera technology (Leica 2000, Leica, Heerbrugg, Switzerland) and 
printed using Photoshop 6.0 edition.
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2.5 Electron Microscopy
2.5.1 Preparation of tissues
Fresh tissue was fixed in 4% paraformaldehyde and 0.1% glutaraldehyde. 
Sections were cut on an Oxford vibratome (Lancer) and collected in serial order in 0.1 
M phosphate buffer. They were subsequently dehydrated in ethanol, cleared in 
propylene oxide, and embedded in araldite between two sheets of Melanex (ICI, 
Middlesborough, UK). Semi-thin (1 pm) sections were cut with glass knives and 
stained with toludine blue adjacent to thin sections (70 nm), cut with a diamond knife 
on a Reichert Ultracut ultramicrotome (Leica CM 3050, Nussloch, Switzerland). The 
sections were collected on copper mesh grids coated with a thin Formvar film (Agar 
Scientific, Stansted, UK), counterstained with lead citrate.
2.5.2 Electron microscopy and photography
Sections were viewed in a JEOL 1010 transmission electron microscope 
(JEOL instruments, Akishima, Japan). Plate photographs were taken which were 
scanned using Imax Scanner and produced in Photoshop 6.0 edition.
2.6 Ethical approval and animal licence
Ethical approval was obtained for the collection and study of human tissue, 
reference RREC 2662. All patients were individually consented and given a copy of 
their consent form together with an information sheet regarding the study. Stored 
tissue was anonymously catalogued. Schedule 1 sacrifice was carried out after 
accreditation under the Animals (Scientific Procedures) Act 1986 reference 
RVC/00/183. Bladder outlet obtruction was performed in rats under the Animals
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(Scientific Procedures) Act 1986, personal licence reference PIL 70/16636 in 
conjunction with project licence PPL 70/4678.
2.7 Drugs and solutions
Acetylcholine Sigma
Adenosine 5’-triphosphate sodium salt 
a,P-Methylene adenosine 5’-triphosphate salt 
P,y-Methylene adenosine 5’-triphosphate salt 
Ascorbic acid 
Atropine sulphate 
Carbachol
Biotinylated donkey anti-rabbit IgG 
ExtrAvidin-horseradish peroxidase 
Formvar film 
Glucose oxidase 
Hydrogen peroxide 
Indomethacin 
Methanol 
Melanex 
Noradrenaline 
Normal Horse Serum 
Paraformaldehyde 
Picric acid
Pyridoxalphosphate-t-azophenyl-2’,4’-disulphonic acid Sigma 
Tetrodotoxin Sigma
Sigma
Sigma
Sigma
Sigma
Antigen Pharmaceuticals 
Sigma
Jackson Immunoresearch 
Sigma
Agar Scientific
Sigma
Sigma
Sigma
Analar
ICI
Sigma
Gibco
Sigma
Sigma
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CHAPTER 3
SMOOTH MUSCLE, AND PURINERGIC 
CONTRACTION OF THE HUMAN, RABBIT, RAT 
AND MOUSE TESTICULAR CAPSULE
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3.1 Abstract
The smooth muscle cells of the testicular capsule (tunica albuginea) of man, 
rat and mouse were examined by electron microscopy. They were characteristically 
flattened, elongated, branching cells and diffusely incorporated into the collagenous 
matrix and did not form a compact muscle layer. Contractile and synthetic smooth 
muscle cell phenotypes were identified. Nerve varicosities in close apposition to 
smooth muscle were seen in human tissue.
Contractile responses induced by ATP, a,P-meATP, NA, ACh and EFS of 
autonomic nerves were investigated. Nerve-mediated responses of the rabbit and 
human were recorded. The EFS-induced responses of human tunica albuginea smooth 
muscle were completely abolished by prazosin. In the rabbit, EFS-induced contractile 
responses were reduced by pyridoxalphosphate-6-azophenyl-2’,4’-disulphonic acid 
(PPADS) by 36 % and by prazosin by 77%. Both antagonists together, almost 
completely abolished all EFS-induced contractions. The human tunica albuginea was 
contracted by NA, ATP and a,P-meATP, but not by ACh. The rabbit and rat tunica 
albuginea were contracted by NA, ATP, a,P-meATP and ACh. The mouse tunica 
albuginea was contracted by ACh, ATP and a,P-meATP, but relaxed to NA.
Immunohistochemical studies demonstrated that P2Xi and P2X2 receptors 
were expressed on the smooth muscle of the rodent and human testicular capsule.
The testicular capsule of all the species examined contained contractile smooth 
muscle. ATP, released as a co-transmitter from sympathetic nerves can stimulate the 
contraction of rabbit smooth muscle. Human, rat and mouse testicular smooth muscle 
demonstrated purinergic responsiveness, probably mediated through the P2Xi and/or 
P2X2 receptors.
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3.2 Introduction
There is increasing evidence for falling sperm counts in man (Carlsen et al., 
1992; Joffe, 1996). Despite the WHO standardization of semen analysis parameters 
(Rowe et al., 2000), it is difficult to define ‘normal’ in the multiple parameters of 
semen analysis, and there is widespread variation in laboratory measurement of semen 
analysis (Keel, 2004). Semen analysis is the end-product of sperm production, 
transport and ejaculation through the genito-urinary system. A reduction in sperm 
numbers may reflect reduced transportation through the genital tract, rather than 
reduced production. For instance, in young healthy volunteers, who gave a minimum 
of 5 samples in the course of a year, sperm concentration varied by an average of 4.8 
fold with the maximum difference being 17.2 fold (Oshio, 2004). There is no clinical 
or laboratory measure of sperm transport failure, and exceedingly limited objective 
evidence for the mechanisms of sperm transport, with much evidence implied from 
relatively dated anatomical studies. It may therefore be that a significant number of 
patients labelled as idiopathic oligospermia have a degree of failure of the transport 
process rather than spermatogenesis. This subset of infertile patients is potentially 
amenable to stimulation of genital smooth muscle with either adrenergic or purinergic 
stimuli, should such an agent become available.
Our knowledge of the basic contractile mechanisms, and the frequency of such 
contractions in propelling sperm through the genital tract is surprisingly deficient. It is 
postulated that contraction of the tunica albuginea is one mechanism propelling sperm 
from the seminiferous tubules into the head of the epididymis (Hargrove et al., 1977). 
Since the demonstration of contractile smooth muscle in the tunica albuginea in the 
late 1960s, our understanding of autonomic signalling has advanced with the 
acceptance of purinergic co-transmission. The biphasic nature of vas deferens
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contraction was instrumental in this acceptance (Sneddon and Westfall, 1983), and the 
importance of purinergic signalling in the contraction of genital smooth muscle has 
been confirmed by P2Xi receptor deficient mice being infertile due to oligospermia, 
secondary to reduced vas deferens contraction (Mulyran et al., 2000). Contraction of 
the human vas deferens has recently been shown to have a significant purinergic 
component (Banks et al., 2006). The testicular capsule can be considered to be the 
most proximal part of the vas deferens, and in conjunction with the seminiferous 
tubules, constitutes the origin of the genital tract. Contraction of the tunica albuginea 
may be essential in moving sperm out of the testis and it is important to our 
understanding of sperm transport, that the contractile mechanisms governing the 
smooth muscle contraction are characterised.
This was a comparative study which examined the testicular capsule smooth 
muscle elements from man, rabbit, rat and mouse. The role of purinergic co­
transmission in the contraction of the tunica albuginea smooth muscle was examined 
by electrical field stimulation of autonomic nerves, and the exogenous application of 
purinergic and autonomic agonists. The distribution of P2X receptors was examined 
by immunohistochemistry.
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3.3 Methods
See Chapter 2
Human testes were obtained from patients undergoing orchidectomy for 
gender reassignment (n=5, ages 23-47) or metastatic prostate cancer (n=5, ages 67- 
88). Ethical approval was obtained, reference number RREC 2662. All patients were 
given verbal and written information prior to giving informed consent. A copy of the 
consent form was given to the patient and a further copy filed in the medical notes. 
Tissue was stored anonymously. All gender reassignment patients had ceased 
supplementary oestrogen therapy at least 6 weeks prior to operation.
Animal testes were obtained from adult male Sprague-Dawley rats (300-360 g, n=5), 
mice (35-42g, n=5) and rabbits (3kg, n=3).
Organ-bath studies were carried out at 35°C, to approximate to scrotal temperature.
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3.4 Results
3.4.1 Electron microscopy
In the three species examined (man, rat, mouse) two layers of testicular 
capsule were identified. The main substance of the capsule was the tunica albuginea 
consisting of dense connective tissue and smooth muscle cells (Fig 3.1a). An inner 
layer, the tunica vasculosa, was identified which contained loose connective tissue 
incorporating the vasculature and nerve bundles. Previous investigators identified an 
outer mesothelial layer, one cell in thickness, termed the tunica vaginalis visceralis. 
This was not visualised in our preparations, though it has been reported that this is 
often lost in tissue preparation (Davis et al., 1970).
The three species examined demonstrated a similar distribution of smooth 
muscle cells within the tunica albuginea. Flattened branching cells were loosely 
arranged in single cell thick sheets with intervening collagenous connective tissue. 
These sheets were closer together on the inner aspect of the tunica albuginea, having 
less intervening collagen between them, but did not form an anatomically distinct 
muscle layer within the tunica albuginea (see Fig 3. lb). The smooth muscle cells were 
mostly arranged in a longitudinal pattern, though those of the human tunica albuginea 
were the least organised of the three species examined (Fig 3.1c). The smooth muscle 
cell appearance varied pending its position within the tunica albuginea. The cells of 
the outer aspect resembled the synthetic smooth muscle phenotype, having a greater 
cytoplasm to nuclear ratio, greater amounts of Golgi apparatus, fewer dense bodies 
and fewer myofilaments. In contrast, the cells of the inner aspect had a more classical 
appearance of the contractile smooth muscle phenotype (Fig 3.1d,e). These cells were 
flatter, had central cylindrical nuclei, numerous dense bodies among myofilaments, 
dense plaques adherent to the cell membrane, micropinocytotic vesicles and distinct
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basal laminae except at regions of cell-cell contact. In between smooth muscle cells, 
large amounts of collagen and to a lesser extent elastin were present.
Specialized junctions between smooth muscle cells were seen in all three 
species examined. These consisted of a close apposition between cell membrane of 
smooth muscle cell processes (Fig 3. Id). However, these junctions were not examined 
at sufficiently high resolution to identify them as classical gap junctions.
In the human tunica albuginea proper, nerves, not associated with blood 
vessels. Retracted Schwann cells, in association with vesicle containing axon 
varicosities, were seen in immediate apposition to smooth muscle cells, which were 
strongly suggestive of functional innervation of smooth muscle (Fig le,f). In contrast, 
in the mouse and the rat no nerve fibres were identified within the tunica albuginea. 
Nerves were predominately associated with blood vessels in the tunica vasculosa (Fig 
3.2).
3.4.2 P2X receptor immunohistochemistry
Only minimal P2Xj receptor immunoreactivity was observed in the capsule of 
the human testis. Greater immunoreactivity was observed in the capsule of the rat (Fig 
3.3 a) and the mouse. P2X2 receptor immunoreactivity was observed in all three 
species (Fig 3.3b).
P2 X3 receptors were expressed in a few variable punctate places in the human 
tunica albuginea but minimally so in the other species examined. No smooth muscle 
expression of P2X4-7 receptors was demonstrated in any of the species examined. 
Germ cell expression was observed which confirmed that the antibodies where active.
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3.4.3 Pharmacology
Strips of rabbit tunica albuginea were contractile to EFS of autonomic nerves 
in a frequency-dependent manner with peak contraction occurring at 16 Hz. 
Contractions were biphasic with an initial rapid phase followed by a longer plateau 
phase that took up to 30 seconds to reach a maximal contraction. Subsequent EFS in 
the presence of purinergic antagonist PPADS (30 pM) reduced the maximal 
contraction by 36%. EFS in the presence of the adrenergic antagonist prazosin (1 pM) 
reduced the maximal contraction by 77 %. When both antagonists were used together, 
EFS-induced contraction was almost completely abolished (Figure 3.4a). Some strips 
of human tunica albuginea were contractile to EFS of autonomic nerves in a 
frequency-dependent manner, but contractions were less repeatable and the maximal 
contraction occurred at 32 Hz. Contractions were completely abolished by prazosin 
(Figure 3.4b). In contrast, the rat and mouse tunica albuginea preparations were not 
reproducibly contractile to EFS of autonomic nerves.
Strips of human tunica albuginea contracted to exogenously applied NA, ATP 
and a, [3-meATP in a concentration-dependent manner, although contractions were 
recorded only to the higher doses of ATP tested (Fig 3.5a,b). The orientation of the 
strip did not influence the contractions. The strongest contractions were to NA, with 
the maximal NA contraction approximately 6 times stronger than that of the maximal 
a,p-meATP contraction. Respective ECso values were NA 2.6 pM (95% Cl = 1.5-2.9 
pM) and a,P-me-ATP 5.6 pM (95% Cl = 2.9-11.1 pM). Contractions to ATP did not 
reach a maximum and so an EC50 could not be calculated. No contraction or relaxation 
was recorded to ACh.
Strips of rabbit tunica albuginea contracted to exogenously applied NA, ACh, 
ATP and a,P-meATP in a concentration-dependent manner. The strongest observed
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contractions were to NA then to ACh with ATP and a,J3-meATP being similar. 
Contractions to NA, ACh, ATP and a, P-me ATP did not reach a maximum and so 
EC50 values could not be calculated (Fig 3.6a).
Rat tunica albuginea preparations contracted to ACh, ATP and NA in a 
concentration-dependent manner. The contractions to NA and ACh were very similar. 
Respective EC50 values were NA .68 pM (95% Cl = .3-1.4 pM) and ACh 1.22 pM 
(95% Cl = .09-15 pM). No maximum was reached with ATP so the EC50 could not be 
calculated (Figure 3.6b).
The mouse tunica albuginea contracted in response to ACh in a concentration- 
dependant manner, giving an E C 5 0  value of .58 pM (95% Cl = .3-1.1 pM). The 
capsule was also contractile in response to exogenous ATP, however, no maximum 
was reached (Fig 3.7a). The whole capsule preparation, when pre-contracted with 
ACh at its E C 5 0  concentration, was found to relax in response to the addition of NA in 
a concentration-dependent manner giving an E C 5 0  value of 8.0 pM (95% Cl = 1.8-36 
pM) (Fig 3.7b).
Contractions of mouse and rat tunica albuginea were recorded in response to 
a,P-meATP, however rapid desensitization occurred and so formal concentration- 
response curves were not recorded.
The strips of rabbit testicular capsule demonstrated marked spontaneous 
activity with small contractions occurring at a rate of 140 per hour. Human testis 
strips also demonstrated some spontaneous activity, but only following stimulation 
with NA or ATP. Contractions were less consistent (5/9 preparations), and at a mean 
rate of 75 contractions per hour.
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3.4 Results 
Figure 3.1
(a) Electron-micrographs demonstrating the longitudinally orientated smooth 
muscle (t) arrangement in the tunica albuginea of the rat testis. Smooth 
muscle cells are distributed singularly, embedded in connective tissue. They 
become closer to each other from the outer (O) to the inner (I) aspect of the 
sheet. The tunica vasculosa (TV) can be seen containing a blood vessel (BV). 
Arrows indicate smooth muscle cell bodies. Scale bar =10 pM.
(b) Electron-micrograph of the mouse tunica albuginea demonstrating the 
increasing density of the smooth muscle cells on the inner aspect of the tunica 
albuginea. Arrows indicate smooth muscle cell bodies. Scale bar =2 pM.
(c) Electron-micrograph of human tunica albuginea demonstrating the less 
organised arrangement of smooth muscle cells. Arrows indicate smooth 
muscle cell bodies. Scale bar =10 pM.
(d) Electron-micrograph demonstrating a human smooth muscle cell (M) and the 
process (P) of another smooth muscle cell in area of cell-cell contact (thick 
arrow). Scale bar =1 pM.
(e) Electron-micrograph demonstrating a smooth muscle cell (M) in immediate 
apposition to a vesicle-containing axon profile (*), which is free of Schwann 
cell (S) process. Scale bar =1 pM.
(f) Electron-micrograph demonstrating a smooth muscle cell process (P) close to 
an axon profile, free of Schwann cell process. Scale bar =1 pM.
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Figure 3.1
Figure 3.2
Electron-micrograph showing a typical blood vessel and associated nerve 
bundles (A ) together with Schwann cells (S) running together towards the deeper 
region of the human tunica albuginea. (E = endothelial cell, M = smooth muscle cell, 
S = Schwann cell). Scale bar =2 pM.
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Figure 3.2
Figure 3.3
Immunohistochemistry of tunica albuginea
(a) This transverse section shows some immunoreactivity to the P2Xi receptor 
subtype in the tunica albuginea of the rat. Arrows indicate smooth muscle 
cell bodies. Scale bar = 25 pM.
(b) This longitudinal section shows P2X2 receptor immunoreactivity on human 
tunica albuginea smooth muscle. Arrows indicate smooth muscle cell bodies. 
Scale bar =100 pM.
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Figure 3.4
Frequency-response curves showing frequency-dependent contraction of the rabbit
and human tunica albuginea to EFS.
All symbols show mean % of contraction to KC1 (120 mM) + s.e. mean (n).
(a) Contraction of the rabbit tunica albuginea to EFS (100 V, 0.3 ms, 2-64 Hz,
15 s) («).In the presence of PPADS (30 pM) (▲). In the presence of 
prazosin (1 pM) (▼), and in presence of both PPADS (30 pM) and prazosin 
(1 pM) ( ♦ )  (n=3).
(b) Contraction of the human tunica albuginea to EFS (100 V, 0.3 ms, 2-32 Hz, 
30 s) (■) (n=6). Contractions were completely antagonised by prazosin (1 
p M ) ( n
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Figure 3.5
Concentration-response curves for NA, ATP and a,P-meATP on isolated strips of 
human tunica albuginea. All symbols show mean % of KC1 contraction (120 mM) ± 
s.e. mean (n) (unless masked by symbol) in conjunction with non-linear regression 
curve. Dotted line represents 95 % confidence interval (Cl) of individual values.
(a) Concentration-response curve for NA (■, n=7, strips=l 1).
(b) Concentration-response curve for a,P-meATP (A), (n=7 strips =11) and
ATP (♦ ) , (n=12, strips =16). 95 % Cl not shown for ATP.
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Figure 3.6
Concentration-response curves for NA, ACh, ATP and a,P-meATP on isolated 
strips of rabbit tunica albuginea and whole tunica albuginea preparations of the rat. 
All symbols show mean % of maximum KC1 contraction ± s.e. mean (n), (unless 
masked by symbol), together with non-linear regression curve where appropriate.
(a) Rabbit tunica albuginea. Concentration-response curve for NA (■), ACh 
(•), ATP (♦ X n ^ , strips=3), and a,P-meATP (A), (n=2, strips=2).
(b) Rat whole preparations of tunica albuginea. Concentration-response curve 
for NA (■), ACh (• ) , ATP (♦ ) , (n=6, preparations=12). Red dotted line 
(—) represents 95 % Cl for NA values, and green dotted line (—) represents 
95 % Cl for ACh values.
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Figure 3.7
(a) Concentration-response curves for ACh ( • )  and ATP ( ♦ )  on whole tunica 
albuginea preparations of the mouse. All symbols show mean % of KC1 
contraction + s.e. mean (n), (unless masked by symbol) (n=6 , strips=8 ), 
together with non-linear regression curve. Dotted line represents 95 % Cl for 
ACh values.
(b) Relaxation concentration-response curves of whole preparations of mouse 
tunica albuginea to NA (■), following pre-contraction with ACh at the E C 5 0  
concentration All symbols show mean remaining contraction expressed as % 
of contraction to ACh ( E C 5 0 )  ± s.e. mean, (n=4, strips=4), together with non­
linear regression curve. Dotted lines represent 95 % Cl for NA values.
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3.5 Discussion
Smooth muscle cells were first demonstrated in the tunica albuginea of rabbit 
testes in 1967 (Holstein, 1967). Subsequently, smooth muscle cells have been 
demonstrated in the tunica albuginea of several species including man, rat, guinea pig, 
cat, dog, pig, cow, sheep and horse (Davis et al., 1970; Langford and Heller, 1973; 
Leeson and Cookson, 1974; Ohanian et al., 1979; Chacon-Arellano and Woolley, 
1980; Middendorf et al., 2002). The extent and conformity of the smooth muscle 
arrangement between species is not consistent, and only in the rabbit and man has a 
true layer been demonstrated, and indeed two layers perpendicular to each other have 
been described on the outer aspect of the rabbit tunica albuginea (Holstein and Weiss, 
1967; Middendorf et al., 2002). The density of smooth muscle cells in different areas 
of the tunica albuginea has been shown to be variable (Holstein, 1967). Inter species 
variations exist and it has been suggested that more smooth muscle cells are located at 
the poles and the posterior border of the testis in the rete testicular area (Davis et al., 
1970). In our own studies we found no conclusive pattern or density of smooth 
muscle cells in different areas of the testicular capsule. We found that the smooth 
muscle cell phenotype progressively changed from a secretory phenotype on the outer 
aspect to a more contractile phenotype on the inner aspect of the tunica albuginea. 
This arrangement is largely in agreement with the findings of Middendorfif, who 
confirmed the phenotypic change by immunohistochemistry (Middendorff et al., 
2002). However, we did not observe the inner smooth muscle cells to be a distinct 
layer. This transition and arrangement was seen in all three species examined, but was 
best demonstrated in the thin tunica albuginea of the mouse or rat, in which the entire 
testicular capsule could be observed in the same section. This observation may 
explain the mixed reports regarding the presence of true smooth muscle cells as
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opposed to contractile myofibroblasts, and is in keeping with the observation that a 
smooth muscle cell is not a single entity but represents a heterogenous cell that is both 
contractile and synthetic at opposite ends of the spectrum (Campbell and Campbell, 
1997).
The neuronal supply to the testis appears to vary markedly between species, 
with some immunohistochemical reports of dense networks covering the outer aspect 
of the tunica albuginea with nerves penetrating the substance of the testis and even 
directly innervating Leydig cells (Prince, 1992; Santamaria et al., 1997; Suburo et al., 
2002). Other reports suggest the innervation is sparse and predominantly involved in 
vasomotor control and consequently thermoregulation (Bell et and McLean, 1973; 
Wrobel and Bradl, 1998). In the human testis, myelinated nerves penetrated the tunica 
albuginea, and nerve varicosities containing vesicles were seen in apposition to 
smooth muscle cells, consistent with neurogenic innervation of smooth muscle. The 
strips of human tunica albuginea that did respond to EFS had all been cut either 
parallel or adjacent to a blood vessel that was subsequently removed. This would 
imply that the neurogenic innervation of the smooth muscle is related to nerves 
associated with the blood vessels. In keeping with other investigators we found 
specialised junctions between smooth muscle cells, these were fused areas between 
smooth muscle cells, consistent with myogenic propagation of contraction, although 
no classical gap junctions were identified.
In 1969, Davis and Langford (Davis and Langford, 1969) first demonstrated 
that the rat testicular capsule contracted in response to NA and ACh. The present 
study demonstrated that the rabbit tunica albuginea was contractile to EFS of 
autonomic nerves. The P2 receptor antagonist PPADS reduced the contractile force by 
36% and prazosin by 77 %. In combination virtually no contraction was detected. The
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response of the rabbit tunica albuginea to exogenous a, p-me ATP was 
uncharacteristically lower than that to ATP, which is suggestive that some 
desensitisation of P2Xi receptors may have occurred, as seen in the rat and the mouse, 
or that P2 X2 receptors were involved. In the rabbit, the maximal contractile force 
induced by NA was approximately 4 times that of ATP or a,P-meATP. In contrast the 
human tunica albuginea contraction was completely antagonised by prazosin and the 
maximal contractions induced by NA were approximately 7 times that of a,P-meATP. 
The purinergic neural component of human tunica albuginea contraction may be 
smaller and masked by the adrenergic component. The pattern of a relatively smaller 
purinergic component would be in keeping with other studies on purinergic smooth 
muscle contraction of healthy human genito-urinary smooth muscle (Bayliss et al., 
1999; Bumstock 2004). In keeping with previous findings (Davis and Langford, 
1969) the rat tunica albuginea was contractile to both NA and ACh, although in our 
study we found marginally greater contractility with NA as opposed to ACh. In all the 
species examined, we have shown for the first time that the tunica albuginea is also 
contracted by purinergic agonists. The mouse tunica albuginea demonstrated a 
different pharmacological contractile profile to that of the rat and rabbit, where the 
tunica albuginea contracted to ACh and ATP, but relaxed to NA.
In other tissues, where purinergic co-transmission is demonstrated, such as the 
vas deferens or bladder, the contraction is classically biphasic with an initial rapid 
phase being attributable to ATP and a second slower phase attributable to either NA 
or ACh respectively (Fedan et al., 1981; Meldrum and Bumstock, 1983; Sneddon et 
al., 1984). The contraction of rabbit tunica albuginea to EFS was demonstrated to be 
biphasic. In the human tunica albuginea, where adrenergic transmission dominates, 
contraction to EFS was monophasic and contraction to exogenous agonists was slow,
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taking up to 1 minute to reach maximum. This slow pattern was similar in the rat and 
the mouse.
ATP-induced smooth muscle contractions have been studied in other tissues 
and it is established that contraction is mediated through the P2Xi receptor. a,J3- 
meATP is selective for P2Xi and P2X3 receptors. P2X3 receptors are largely 
expressed on sensory nerves involved in nociception (Bumstock, 2000; 2003), which 
suggests that smooth muscle contraction is largely mediated through the P2Xi 
receptor subtype, with the exception of the rabbit where contractions to a,(3-meATP 
were substantially less than ATP and P2 X2 receptors may be involved. 
Immunohistochemical studies using the seven P2X receptor subtype antibodies 
weakly demonstrated the presence of P2Xi receptors on the smooth muscle 
membrane. There was also expression of P2 X2 receptors on smooth muscle cells, 
although often located intracellularly. Staining of both P2Xi and P2 X2 receptors was 
generally low when compared to other tissues, such as the vas deferens, bladder and 
arteries. This is partly a reflection of the small smooth muscle content within testes 
and the relatively small purinergic component, at least in healthy tissues.
Sperm contained within the testis lack forward progressive motility and this is 
subsequently gained in the distal epididymis in man and rats (Hoskins et al., 1978; 
Yeung et al., 1993; Jeulin et al., 1996). A pressure gradient would move sperm out of 
the testis and it is postulated that contraction of the testicular capsule and myoid cells 
of the seminiferous tubules may generate this (Hargrove et al., 1977; Ellis et al., 1982; 
Maekawa et al., 1996). Fluid production within the testis would also create pressure 
and movement of the fluid would have the additional benefit of effectively carrying 
sperm out of the testis on an effluent tide. Movement of the ciliated cells of the ducti 
efferenti at the junction of the rete testis and caput epididymis were previously
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thought to move sperm into the epididymis but this has been disproved due to the 
demonstration of normal numbers of sperm in the epididymis in patients with 
Kartagener’s syndrome, in which cilia are immobile (Afzelius, 1976). Studies using 
radio-opaque sperm injected into the epididymis of rabbits have shown significant 
antegrade and retrograde movement of sperm from the epididymis (Prins and 
Zaneveld, 1980). As sperm are present in the ejaculate despite an absence of sexual 
activity it must be assumed that tunica albuginea contraction occurs subconsciously 
and without the need for physical sexual stimulation. In this study the rabbit tunica 
albuginea demonstrated marked spontaneous activity at a rate of approximately 140 
per hour and the human tunica albuginea also demonstrated spontaneous contraction 
at a lower rate of 75 contractions per hour. Spontaneous contractions of the human 
and rabbit testis have been previously reported (Davis et al., 1970; Middendorff et al., 
2002).
Concern has been raised over progressively falling sperm counts (Carlsen et 
al., 1992; Joffe, 1996). It is possible that this is, in part, due to a failure of sperm 
transport rather than spermatogenesis. Developmental studies have demonstrated that 
the development of testicular smooth muscle is coincidental with sexual maturity 
(Leeson, 1977; Leeson and Forman, 1981; Holt et al., 2004). This study has 
demonstrated an ultrastructural and pharmacological basis for testicular capsule 
contraction, which may play an essential role in moving sperm from the testis to the 
epididymis. This process is common to all species examined. Purinergic co­
transmission was evident in the rabbit, and purinergic responsiveness was 
demonstrated in man, rats and mice. We suggest that continuous flux of spermatids 
from the seminiferous tubules within the testis into the rete testis and epididymis may 
be caused in part by low pressure, spontaneous contractions of the smooth muscle of
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the tunica albuginea. Larger volume flux may be caused by slow, sustained 
contractions induced by sympathetic, parasympathetic and purinergic stimuli, as may 
be induced by sexual arousal. In man, this process is dominated by the adrenergic 
system in association with a smaller purinergic component, that maybe consistent 
with purinergic co-transmission, but is without a parasympathetic component. 
Sympathetic stimulation may have a role in improving sperm counts.
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CHAPTER 4
THE PURINERGIC COMPONENT OF HUMAN 
VAS DEFERENS CONTRACTION
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4.1 Abstract
The aim of this study was to examine purinergic signalling in the human vas 
deferens. Strips of human vas deferens from the epididymal end were suspended in an 
organ bath and subjected to electrical field stimulation to establish ffequency-response 
curves. These were repeated in the presence of the P2 antagonist pyridoxalphosphate- 
6 -azopheny 1-2’,4’-disulfonic acid (PPADS, 30 pM), the adrenergic ai antagonist, 
prazosin (1 pM) and tetrodotoxin (1 pM). Concentration-response curves were 
obtained by the exogenous application of NA and the P2X agonists ATP and the non- 
hydrolysable analogue a,p-meATP. The P2X receptor subtype distribution was 
assessed by immunohistochemistry using specific antibodies.
The response at 32 Hz in the presence of PPADS was reduced by 40% and in 
the presence of prazosin by 80%. NA caused concentration-dependent contractions 
(the EC so was 11.8 pM). ATP also caused concentration-dependent contractions. 
Contractions to a,P-meATP ( E C 5 0  value = 6.27 pM) suggested that the fimctional 
receptor was P2Xi and/or P2 X3. However, immunohistochemistry demonstrated 
P2Xi, but not P2 X3 receptor immunoreactivity on the smooth muscle cells. In 
summary, this study has demonstrated that ATP is a co-transmitter with NA in the 
contraction of the human vas deferens predominantly acting through the P2Xi 
receptor.
4.2 Introduction
ATP, co-released with NA from sympathetic nerves and ACh from 
parasympathetic nerves, acting through P2X receptors, has been shown to cause 
contraction of genito-urinary smooth muscle of mammals (Bumstock, 1995; 2001).
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This purinergic component of smooth muscle contraction is variable between tissues 
and species. The functional importance of co-released ATP demonstrated in 
laboratory animals is not always mirrored in human tissue. For instance, in the rabbit 
bladder the purinergic component of the parasympathetic mediated contraction is 
accountable for up to 40% of the smooth muscle contraction (Calvert et al., 2001), 
and in the guinea-pig up to 70% (Meldrum and Bumstock, 1983). In the normal 
human bladder it is very small, although in the pathological states such as detrusor 
instability, and interstitial cystitis, the purinergic component becomes significant, 
accounting for up to 40% of the contraction (Palea et al., 1993; Bayliss et al., 1999; 
O’Reilly et al., 2002).
NA and ATP have been shown to mediate contraction of the rat and guinea pig 
vas deferens smooth muscle. The contraction, in response to EFS of sympathetic 
nerves has been shown to be biphasic (Fedan et al., 1981; Meldrum and Bumstock, 
1983; Sneddon et al., 1984). ATP, released from sympathetic nerves, acts through 
ion-gated P2X receptors to stimulate the initial fast phase of the contraction, with co­
released NA causing the more sustained, but slower contraction, acting through G 
protein-coupled a  adrenoceptors.
P2Xi receptors have been demonstrated on the smooth muscle membrane of 
the vas deferens, where it mediates contraction (Vulchanova et al., 1996; Hansen et 
al., 1999; Lee et al., 2000a; b; Mulryan et al., 2000). The functional relevance has 
been confirmed by the demonstration that P2Xi receptor null mice were shown to 
have a 90% reduction in fertility due to reduced vas deferens contraction, although 
their sperm were fertile. It was subsequently suggested that P2Xi antagonists could be 
developed for male contraception (Mulyran et al., 2000).
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The role of ATP as a co-transmitter and the distribution of the P2Xi receptor 
in the human vas deferens have yet to be fully examined. This study examined the 
purinergic component of human vas deferens smooth muscle contraction in response 
to EFS of autonomic nerves, and also, the contractile effects of purinergic and 
adrenergic agonists. The tissue distribution of the P2X receptor subtypes was also 
examined by immunohistochemistry.
4.4 Methods
See Chapter 2
The hospital ethical committee granted approval for this study. Human tissue 
was taken from patients either undergoing a vasectomy for contraception or 
orchidectomy for metastatic prostate disease. Patients were fully informed and gave 
prior consent.
Each vas deferens was divided longitudinally into specimens measuring 
approximately 2 x 20 mm. An initial load of 1 g was applied at the start of each 
experiment.
4.3.1 Frequency-response curves
Strips of vas deferens were subjected to EFS (100 V, 0.5 ms, 1-64 Hz, 20 s) 
every 5 min. Three frequency-response curves were carried out to establish consistent 
contractile responses. Frequency-response curves were subsequently constructed after 
20 min in the presence of prazosin (1 pM), or PPADS (30 pM) to establish the 
relative adrenergic and purinergic components of the contraction. Further frequency- 
response curves were then constructed in the presence of both antagonists, and then
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finally in the presence of TTX (1 pM), to determine the part of the response due to 
direct electrical stimulation of smooth muscle. The Krebs solution in the organ bath 
was changed between each set of frequency-response curves.
4.3.2 Concentration-response curves
Non-cumulative concentration-response curves were constructed for NA (0.1- 
300 pM), ATP (0.1 pM-1 mM) and a, P-me ATP (0.1-300 pM). Boluses of a,p- 
meATP were applied at least 20 minutes apart to avoid desensitisation of the P2Xi 
receptor.
4.3.4 Immunohistochemistry
See general methods, chapter 2. All seven P2X receptor antibodies were 
diluted to 2.5-5 pg/ml.
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4.4 Results
4.4.1 Pharmacology
EFS of sympathetic nerves of the vas deferens induced frequency-dependent 
contractions. These contractions were predominantly monophasic (Fig 4. la, Id), but 
became rhythmic at the highest frequencies. It was found that the maximum 
contraction was achieved at 32 Hz. The neurogenic contraction was significantly 
reduced by the a i- adrenoceptor antagonist prazosin by over 80% at peak frequency 
(Fig 4.1b, Fig 4.2) (P=0.0001). EFS-induced contractions in the presence of the P2X 
receptor antagonist PPADS (30 pM) were also significantly reduced (P<0.0001, Fig 
4. le, Fig 4.2) from the initial contraction (Fig 4. Id, Fig 4.2). This was more evident at 
the higher frequencies. At the peak contraction frequency of 32 Hz this amounted to a 
40% reduction from the initial contraction. Virtually all the neurogenic contraction 
was abolished when the EFS was carried out in the presence of both PPADS and 
prazosin (Fig 4.If). At the lower frequencies tested prazosin almost completely 
abolished the smooth muscle contraction and PPADS caused minimal antagonism. At 
the higher frequencies tested, PPADS caused relatively greater antagonism and 
prazosin relatively less (Fig 4.2). EFS carried out in the presence of TTX resulted in 
some residual contraction, but only at the highest frequencies tested (Fig 4.1c). This 
confirmed that most of the contraction was nerve-mediated.
NA produced a concentration-dependent contraction of the vas deferens, E C 5 0  
value was 11.8 pM (95 % Cl = 9.5-14.6pM) (Figure 4.3a). The contractile responses 
were typically slow rising, with a stimulus to maximal response time of 
approximately 12 s (Fig 4.1g). Supra-threshold rhythmic contractions developed when 
concentrations above 10 pM were used.
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a,p-meATP caused contractions similar to those induced by ATP, but these 
were larger and more consistent (Fig 4.1h). Concentration-response curves obtained 
by using the non-hydrolysable ATP analogue a,[3-meATP did reach a maximum (Fig 
4.3b). Although some desensitisation was noted at the highest concentrations used, the 
EC50 value was calculated to be 9.2 pM (95 % Cl = 5.6-15.1 pM). ATP, when applied 
exogenously produced a small, monophasic response (Fig 4.1i). Responses were less 
consistent and no maximum contraction was obtained despite using concentrations up 
to 1 mM (Fig 4.3b).
Spikes of spontaneous rhythmic contractile activity were observed in 9/14 vas 
deferens preparations. Spontaneous contraction frequency averaged 100 contractions 
per hour, with a mean contractile force of 5.8 mg/mg tissue. ATP, when applied at 
concentrations too low to induce individual contractions, rapidly increased the 
frequency and amplitude of these spontaneous contractions for a few seconds (Fig 
4. lj). Spontaneous contractions were usually only observed following stimulation by 
exogenous agonists or EFS and were not completely abolished by TTX.
4.4.2 Immunohistochemistry
P2Xi receptor expression was observed on the smooth muscle membranes in 
the outer longitudinal and middle circular muscle layers. Minimal expression was 
observed on the inner longitudinal layer (Fig 4.4a). At higher magnification, it 
appeared that the P2Xi receptor expression was non-homogenous both in terms of the 
number of smooth muscle cells on which it was expressed and on single smooth 
muscle cells with expression being greater on some areas of the membrane (see Fig 
4.4b). Expression of P2 X2 receptors was also noted in a similar pattern, but more 
diffusely distributed and in an intra-cellular position (Fig 4.4c,d). No expression of
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other P2X receptor subtypes was observed on the smooth muscle. In control studies, 
no expression was observed in the absence of the primary antibody or following pre- 
adsorption of the primary antibody with its cognate peptide.
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4.4 Results 
Figure 4.1
Typical traces of responses to EFS, in the presence and absence of antagonists and 
individual responses to agonists. Start of time scale indicates the start of nerve 
stimulation or application of agonist to organ bath.
(a) Response to EFS at lOOv, 0.5ms, 32 Hz for 20s in absence of antagonist
(b) Stimulation in the presence of prazosin (1 pM).
(c) Stimulation in the presence of TTX (1 pM).
(d) Response to EFS in absence of antagonist.
(e) EFS in the presence of PPADS (30 pM).
(f) EFS in the presence of both PPADS (30 pM) and prazosin (1 pM).
(g) Response to NA (100 pM).
(h) Response to a,P-meATP (300 pM).
CO Response to ATP (1 mM).
0 ) Spontaneous contraction and subsequent reaction after ATP (10 pM).
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Figure 4.2
Frequency-response curve showing control contraction (■), then in the presence of 
PPADS (30 pM) (□), or prazosin (1 pM) (o), and then both PPADS (30 pM) and 
prazosin (1 pM) (V). The contractions have been corrected for the TTX insensitive 
component, (n=6, all symbols show % max contraction ± s.e. m).
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Figure 4.3
(a) Concentration-response curve to NA (•),(().05 jiM-300 pM) (n=14).EC5o
value =11.8 pM, (95 % Cl = 9.5-14.6pM).
(b) Concentration-response curve to a,|3-meATP (0.1 pM-300 pM)(V), and 
ATP (0.1 pM-1 mM) (□) (n=10). a,P-meATP E C 5 o  value = 9.2 pM, (95 % 
Cl =5.6-15.1 pM). E C 5 0  not calculated for ATP as no maximum reached and 
range not shown.
All symbols show mean % max KC1 contraction ± s.e.m., dotted line (—) 
indicates 95 % Cl of individual values. The bold line indicates non-linear 
regression curve where a maximum contraction was obtained.
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Figure 4.4
Photomicrographs demonstrating P2Xj and P2 X2 receptor immunolocalisation on
smooth muscle of human vas deferens.
(a) Photomicrograph demonstrating P2Xi receptor localisation on outer 
longitudinal (OL) and middle circular (MC) smooth muscle layers. P2Xi 
receptor expression was not observed on the inner longitudinal (IL) layer. 
The lumen is denoted by L. Scale bar 250 pm.
(b) Photomicrograph demonstrating P2Xj receptor localisation on smooth 
muscle membranes. Scale bar 50 pm
(c) Photomicrograph demonstrating diffuse P2X2 receptor expression on smooth 
muscle of the outer longitudinal and middle circular smooth muscle layers. 
Scale bar 125 pm.
(d) Photomicrograph demonstrating P2X2 receptor expression in the cytoplasm 
of smooth muscle. Adapted from immunofluorescence, scale bar 25 pm.
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Figure 4.4
4.5 Discussion
The contraction of vas deferens from mammals such as the rat, rabbit and 
guinea pig in response to sympathetic nerve stimulation has been shown to be bi- 
phasic (Sneddon and Westfall, 1983; Meldrum and Bumstock, 1983; Sneddon et al., 
1984; Fedan et al., 1991). In contrast, the human vas deferens did not contract to 
sympathetic nerve stimulation in a biphasic manner, but rather in a slower 
monophasic manner. At higher frequencies, supra-threshold rhythmic contractions 
were super-imposed. This pattern of contraction was also observed when the vas 
deferens contracted to higher concentrations of NA.
Maximal, nerve-mediated contractions, in the presence of PPADS were 
reduced by 40%. This suggested that the purinergic component of neurogenically 
induced vas deferens smooth muscle contraction at most amounts to approximately 
40%. The purinergic antagonism was not uniform and was much greater at the higher 
frequencies. There was a corresponding reduction in adrenergic antagonism at the 
higher frequencies. This would suggest a differential in the amount of each 
neurotransmitter co-released from sympathetic nerves depending on the extent of 
stimulation. The purinergic component was most evident at maximal stimulation. We 
found that prazosin inhibited the contraction by over 80%, which confirmed that the 
adrenergic component is proportionally dominant, and is mediated through ai- 
adrenoreceptors. The relative adrenergic and purinergic components, as assessed by 
antagonism, amounted to greater than 100%. This implied that synergism between the 
adrenergic and purinergic components existed. Synergism between ATP and NA in 
the vas deferens of other animals has previously been shown (Huidbro-Toro and 
Parada, 1988; Kishi et al., 1990; Witt et al., 1991).
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The P2Xi receptor has been shown to be present on the vas deferens smooth 
muscle membrane in the mouse and rat by immunohistochemistry (Lee et al., 2000a; 
Mulyran et al., 2000). a,P-meATP is specific for the P2Xi and P2 X3 receptor 
subtypes (Khakh et al., 2001). The P2 X3 receptor has been principally demonstrated 
on sensory nerves, and is thought to be involved in nociception rather than smooth 
muscle contraction (Bumstock, 2000). The human vas deferens contracted to a,P- 
meATP in a concentration-dependent manner; which would suggest that the 
functional receptor on smooth muscle in human vas deferens is also the P2Xi subtype.
The pharmacological evidence was further supported by the 
immunohistochemical demonstration of P2Xi, but not P2X3 receptor expression on 
the outer longitudinal, and middle circular layers of smooth muscle. Expression was 
greatest on the outermost smooth muscle. P2X2 receptor expression was also 
demonstrated in the outer longitudinal, and middle circular layers of smooth muscle 
cells of the human vas deferens. This distribution was similar to that of the P2Xi 
receptors. Previous investigators have demonstrated a similar pattern of expression in 
the rat vas deferens (Burton et al., 2000) although one study reports P2Xi receptor 
expression of the inner longitudinal muscle of the rat vas deferens (Lee et al., 2000a). 
P2X3 receptor expression was not observed on the smooth muscle cells of the vas 
deferens of mice and rats. In the human vas deferens, sympathetic nerves run in the 
adventia and then spread into the muscularis forming an intramural network. A sub­
mucosal plexus staining for acetylcholinesterase has also been demonstrated (Dixon et 
al., 1998). It has been shown that in the human vas deferens, the ratio of nerve 
varicosities to smooth muscle is of the order of 1:30, whereas in the rat the ratio is as 
much as 1:1 (McConnell et al., 1982). A previous study demonstrated that large 
clusters of P2Xi receptors are present on smooth muscle opposite varicosities (Hansen
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et al., 1998) whereas small clusters are not localised near varicosities. On this basis, in 
human vas deferens one would expect fewer clusters of P2Xi receptors than in the rat, 
which may explain the relative paucity of staining in the human vas deferens 
compared to the rat vas deferens. It would also explain the relatively greater P2Xi 
receptor expression on the outer smooth muscle layer, as the nerve density is greater 
in the outer smooth muscle layer. The purinergic component of vas deferens 
contraction from the rat, rabbit and guinea pig is greater at the prostatic end of the vas 
deferens compared to the epididymal end (Sneddon and Machaly, 1992). If the human 
vas deferens is comparable, then greater expression would be expected in more 
proximal sections of vas deferens. In this study it was not possible to collect proximal 
vas deferens specimens to examine the possibility.
At present, it is unclear exactly when the vas deferens of either laboratory 
animals or man contracts in physiological conditions. It is certainly thought to 
contract during ejaculation, but objective evidence for the timing and frequency of 
contraction is lacking. The tubular structure and three-layered smooth muscle 
arrangement of the vas deferens suggest that it contracts in a peristaltic fashion, 
however, objective evidence for this is lacking. Kimura demonstrated in dogs, that 
following hypogastric nerve stimulation, the epididymal section of vas deferens 
contracted, followed by the prostatic section 5-10 s later (Kimura et al., 1975). 
Radiographic studies in rabbits have demonstrated that dye injected at the vas- 
epididymal junction is moved both towards the urethra, and back into the epididymis 
during sexual rest. Sexual stimulation rapidly moved dye towards the urethra for 
ejaculation, but residual dye was retrogradely transported back to the caudal 
epididymis (Prins and Zaneveld, 1980). In our study, both spontaneous and 
neurogenic-induced contractions of the human vas deferens were demonstrated.
I l l
Autonomic-induced contractions were far more forceful and are probably responsible 
for the main propulsion of spermatozoa through the vas deferens, presumably 
following sexual arousal. Spontaneous contractions may be responsible for the slow 
antegrade and retrograde movement of sperm seen in sexual rest, assuming that sperm 
movement in man mirrors that of the rabbit. In the majority of preparations, 
spontaneous contractile activity was observed at a mean frequency of 100 per hour. In 
keeping with previous observations spontaneous activity was only observed following 
initial stimulation (Smith and Bray, 1990). Consistent with other investigators, we 
found a small part of the evoked response of the human vas deferens to be TTX- 
insensitive (Smith and Bray, 199; Hedlund et a l ., 1985). TTX reduced the frequency 
and amplitude of these spontaneous contractions, but did not abolish them completely. 
These observations would suggest that inherent myogenic contractions occur in the 
vas deferens, particularly following stimulation. Exogenously applied ATP 
potentiated both the frequency, and the amplitude of spontaneous contractions. 
Studies have claimed dense expression of P2 X2 receptors on the lamina propria of the 
mouse, rat and guinea pig vas deferens (Burton et al., 2000). However, the role of the 
P2X2 receptor has yet to be elucidated. Evidence is emerging for a possible action on 
the pacemaker cells of the myenteric plexus of the intestine where expression is on the 
interstitial cells of Cajal (Bumstock and Lavin, 2002). Whilst P2X2 receptor 
expression on the lamina propria was not observed in our preparations, some diffuse 
expression on smooth muscle was noted. If the P2X2 receptor does have a pacemaker 
effect, then it may be that the enhancement observed with ATP is due to stimulation 
of the P2X2 receptor. The observation of spontaneous contractions in the human vas 
deferens would suggest ‘background’ antegrade or retrograde spermatozoan
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movement, supplemented by relatively large volume movement due to forceful vas 
deferens contractions, induced by autonomic stimulation secondary to sexual arousal.
This study has demonstrated that the human vas deferens smooth muscle is 
contractile not only to adrenergic agonists, but also purinergic agonists. The 
adrenergic system has been shown to be functionally dominant, however purinergic 
co-transmission has also been shown to be functionally important in the contraction of 
human vas deferens in the in vitro-setting. P2Xi and P2 X2 receptor expression has 
been demonstrated on human vas deferens smooth muscle. These physiological and 
immunohistochemical studies have suggested that the functional receptor in smooth 
muscle contraction is the P2Xi subtype. These findings are in keeping with other 
species examined. ATP has been shown to modify spontaneous contractions, which 
suggests the regulation of background contractions by purinergic mechanisms. It is a 
possibility that by analogy with the human bladder that the ATP component of 
autonomic contraction is altered in pathological conditions (Palea et al., 1983; 
O’Reilly et al., 2002). The possibility of P2Xi antagonists having a contraceptive role 
remains an exciting future development. Alternatively adrenergic and purinergic 
stimulation may be indicated in thetreatment of idiopathic oligospermia as suggested 
by 2 small case series, in which ephedrine or pseudoephedrine was used to stimulate 
aperistaltic vas deferens (Tiffany and Goldstein, 1985; Tillem and Mellinger, 1999).
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CHAPTER 5
CHANGING P2X RECEPTOR EXPRESSION ON 
MATURING SPERM IN THE EPIDIDYMIDES OF 
MICE, HAMSTERS, RATS AND MAN
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5.1 Abstract
Sperm passing from the testis into the caput epididymidis are unable to 
penetrate an oocyte and are immotile. These features develop as spermatozoa pass 
along the length of the epididymis. ATP is increasingly being shown to have trophic 
effects through the activation of P2 receptors. A number of P2X receptor subtypes 
have been demonstrated on developing spermatids in the rat testis, with changing 
expression pending on the stage of development. In the present study, P2Xi,2 and 3 
receptor expression was immunohistochemically demonstrated on the head of 
immature sperm in the human, mouse, hamster and rat caput epididymidis. P2X* 
receptor expression was also observed on the head of sperm in the caput epididymidis 
of mice, hamsters and man, but not rat. There was a subsequent loss of receptor 
expression on sperm in the cauda epididymidis, except in man where expression of 
P2Xj receptors persisted. Comparision with PNA binding studies suggested the P2X 
receptors were located on the acrosome membrane. The change in expression of 
receptor subtypes is coincidental with the functionally essential morphological and 
maturational changes seen in sperm as they travel through the epididymis, and is 
suggestive of a role for purinergic signalling in sperm maturation.
5.2 Introduction
The daily sperm production from the human testes is estimated to be between 
45 and 207 million sperm per day (Freund, 1962; Amann and Howard, 1980). Sperm 
leaving the testis are immature, and lack both forward motility and zona pellucida 
binding capability (Consentino and Cockett, 1986). These functions develop during 
the passage through the epididymis, following the interaction of sperm with the
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epididymal microenviroment and epithelium (Jones, 1998; 1999). The epididymal 
epithelium progressively changes along the length of the epididymis, and the 
epididymal microenviroment is extremely complex, containing more than one 
hundred proteins and ions (Syntin et al., 1996; Dacheux et al., 2003). The epididymis 
is common to most animals, and is macroscopically divided into 3 regions, the caput, 
corpus and cauda, with each section being microscopically distinct (Chandler et al., 
1981; Jones, 1999). The epididymis length is variable being approximately 4 metres 
in man (Turner, 1978), and in excess of 40 metres in bovines (Hoskins et al., 1978). 
The epididymal transit time mirrors this length variation, being between 2 and 16 days 
depending on species (Amann et al., 1976; 1980).
P2X receptors are increasingly being found to have novel trophic and 
apoptotic actions within tissues, as well their established role in purinergic co­
transmission and pain initiation (Bumstock and Knight, 2004). Sperm synthesise their 
own ATP, and although seminal fluid and sperm have a high ATP content, there is no 
correlation with fertility (Jeulin and Soufir, 1992; WHO, 1992; Minelli et al., 1999). 
Anatomically-dependent P2 receptor expression has been noted on the mouse 
epididymal epithelium. Immunohistochemistochemistry demonstrated P2X 1 ,2 ,4 ,a n d  7  
receptors on clear cells in the corpus and proximal cauda epididymal epithelium, with 
only P2X2 receptor expression on the clear cells of the initial segment. RT-PCR also 
demonstrated P2X* and P2Yi receptors in all epididymal segements as well as P2Y2 
receptor expression in the caput and corpus epididymal epithelium. Dynamic function 
of these receptors was confirmed by the demonstration of calcium flux on stimulation 
with ATP, and it was suggested that these receptors are important for the ionic 
maintenance of epididymal fluid (Shariatmadari et al., 2003). Epididymal cell culture 
studies also support ATP-induced changes in the anion and fluid secretion by the
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epididymis (Wong, 1988). The complex membranous changes termed the acrosome 
reaction, which sperm undergo prior to fertilization can be induced by ATP, and such 
stimulated sperm have higher fertilization rates (Rossato et al., 1999). Previously, 
P2 X2 a n d  3  receptor expression has been demonstrated on the acrosome of testicular rat 
spermatids in developmental stages I to VIII, and P2X5 receptor expression in stages 
X to XIII (Glass et al., 2001). To date there are no reports of P2X receptor expression 
on epididymal sperm despite the demonstration of P2X receptors on more immature 
sperm within the testis, evidence for purinergic signalling within the epididymis, and 
improved fertility rates with ATP-activated sperm. This study investigated the 
expression of P2X receptors on maturing sperm within the epididymis of mice, 
hamsters, rats and man.
5.5 Methods
See Chapter 2
Human epididymides were obtained from patients undergoing orchidectomy 
for prostate cancer (n=5, age range 67-88). Mouse, rat and hamster epididymides were 
obtained following sacrifice under Schedule 1 conditions. Epididymides were divided 
into respective caput and cauda ends. Sections from each end were placed on the same 
slide to ensure identical conditions for immunohistochemistry. Antibodies to all seven 
subtypes of P2X receptors were used at concentrations from 0.25-5 pg/ml. Peanut 
agglutinin antibodies were used for identification of the spermatid acrosome diluted to 
lOpg/ml.
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5.4 Results
P2Xi receptors were expressed on the sperm head from sperm contained in the 
caput epididymides of mice (Figure 5.1a), hamsters, rats and man. This expression 
was most pronounced in the most proximal sections of the caput epididymides, and in 
the rat, expression was only present on sperm contained in the ducti efferenti. In the 
rodent species, expression reduced progressively through the epididymis and was 
absent on sperm in the cauda epididymidis. Some persistence of expression was noted 
in sperm in the human cauda epididymis. The smooth muscle surrounding the distal 
tubules of the cauda epididymidis in the mouse strongly expressed P2Xi receptors 
(Figure 5.1b).
P2X2 receptors were demonstrated in a similar pattern to P2Xi receptors, with 
expression on the sperm head of sperm in the caput epididymidis, but expression was 
absent on sperm in the cauda epididymidis. Expression was only seen on sperm in the 
most proximal sections of cauda epididymidis in man and rats (Figure 5.1c,d).
P2X3 receptor expression was demonstrated on sperm heads on the sperm of 
the caput epididymidis from all species, with subsequent loss of expression on sperm 
in the cauda epididymidis.
P2X* receptor expression was observed on sperm from the caput epididymidis 
in all species, except the rat. In the hamster and mouse, expression was strong in the 
caput epididymis (Figure 5.1e) and declined throughout the epididymis. Some 
expression persisted in the proximal cauda epididymis (Figure 5.If) but was absent on 
sperm in the most distal cauda epididymis (Figure 5.1g). In man, some P2 X4 receptor 
expression seen on caput epididymidis sperm (Figure 5.2a) persisted on sperm 
contained in the most distal cauda epididymidis. (Figure 5.2b).
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No expression of P2Xsj6 ^  7 receptors was observed on the sperm in either the 
caput or cauda epididymides in any species examined.
The density of human sperm within the epididymal lumen was markedly less 
than the other species examined and many tubule cross sections did not demonstrate 
sperm. Significant debris was seen in sections of distal cauda epididymidis of rats and 
man, consistent with apoptotic sperm. It was therefore important to ensure the 
integrity of the acrosome. PNA lectin is known to bind to the intact acrosome 
(Mortimer, 1987), and in this study it confirmed the integrity of the acrosome on 
sperm in both caput and cauda epididymis (Figure 5.2c). In the symmetrical human 
and mouse sperm, PNA lectin predominantly bound to the equatorial segment of the 
acrosome. P2X receptor expression, when used with fluorescence, was found to be 
identical to that of PNA lectin and studies using consecutive slides confirmed this 
(Figure 5.2d). In the sickle shaped asymmetrical rat sperm the PNA expression bound 
to the acrosome in a classical sickle pattern (Figure 5.2e).
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5.4 Results 
Figure 5.1
Positive expression indicated by black precipitate. Sperm indicated by thin
arrows. S=sperm, E=epithelium, SM=smooth muscle. Scale bars = 100 pm
(a) Photomicrograph showing sperm in mouse caput epididymidis expressing 
P2Xi receptors.
(b) Photomicrograph showing sperm in the mouse cauda epididymidis no 
longer expressing P2Xj receptors. There is strong expression of P2Xi 
receptors on the smooth muscle surrounding the distal tubule of the cauda 
epididymidis.
(c) Photomicrograph showing sperm in the rat caput epididymidis expressing 
P2X2 receptors.
(d) Photomicrograph showing sperm in the rat cauda epididymidis no longer 
expressing P2X2 receptors.
(e) Photomicrograph showing sperm in the hamster caput epididymidis 
expressing P2 X3 receptors.
(f) Photomicrograph showing a reduction in expression of P2 X3 receptors on 
sperm in hamster cauda epididymidis.
(g) Photomicrograph showing a loss of expression of P2 X3 receptors on sperm 
in the most distal tubule of the hamster cauda epididymidis.
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Figure 5.2
Positive expression indicated by black precipitate or bright fluorescent yellow/green.
Sperm indicated by thin arrows. S=sperm, E=epithelium. Scale bars = 50 pm.
(a) Photomicrograph showing sperm in human caput epididymidis expressing 
P2 X4 receptors.
(b) Photomicrograph showing persistent expression of P2 X4 receptors on sperm in 
the human cauda epididymidis.
(c) Photomicrograph showing fluorescent PNA binding to the symmetrical 
acrosome of human sperm in caput epididymidis.
(d) Photomicrograph showing fluorescent P2Xi receptor expression on the 
symmetrical acrosome of human sperm in caput epididymidis.
(e) Photomicrograph showing fluorescent PNA binding to the asymmetrical 
acrosome of rat sperm in caput epididymidis.
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5.5 Discussion
This study has demonstrated, for the first time, that P2 XU a n d  3  receptors are 
expressed on the head of immature sperm contained within the caput epididymidis of 
mice, rats, hamsters and man. There is a subsequent loss or reduction of P2Xi,2 a n d  3  
receptor expression on mature sperm in the cauda epididymidis. There was 
persistence of P2 X4 receptor expression on sperm in the cauda epididymidis of man 
and mice. The expression is probably on the acrosome, as the immunohistochemical 
pattern was similar to that of PNA which is known to bind to the intact acrosome. The 
developing rat spermatid, within the testis, has been shown to differentially express 
P2X receptors. P2X2 and P2 X3 receptors were demonstrated together on developing 
spermatids in stages I to VIII and were thought to be on the developing acrosome. 
P2 X5 receptors were demonstrated in stages X to XIII in rat testes (Glass et al., 2001). 
The observed P2X receptor expression and subsequent loss, is coincidental to the key 
maturational stage of the epididymis. Anatomically, the proximal epididymidis has a 
distinct epithelium with a high epithelial cell height supportive of a nutrient or 
absorptive function, which contrasts with the low epithelium seen in the cauda 
epididymidis, which appears structurally more appropriate for storage of mature 
sperm (Chandler et al., 1981). Estimates of epididymal sperm storage suggest that 
52% of epididymal sperm are stored in the cauda, 23% in the corpus and 25% in the 
caput, which appears consistent between species (Jones, 1999).
In the normal human epididymidis, it was found that only 22.9% of sperm 
from the distal caput were motile in comparison to 68.3% from the mid to distal 
corpus with a slight reduction in the cauda (Yeung et al., 1993). Human micro- 
canulation studies suggest that the development of motility appears suddenly at the 
junction of the distal caput and proximal corpus epididymidis (Dacheux et al., 1992).
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Similarly it has been demonstrated that the ability of human epididymal sperm to bind 
to zona-free hamster oocytes increased with successive epididymal segments, and that 
only sperm from the cauda epididymidis were able to penetrate the oocyte (Hinrichsen 
et al., 1980). Human studies involving fertility rates following epididymo-vasostomy, 
suggest that only passage through the caput epididymidis is required for fertility, 
although fertility rates increased with more distal anastomoses (Schoysman, 1986).
During epididymal sperm maturation, the plasma membrane undergoes 
remodelling by the uptake of secreted glycoproteins, removal and utilization of 
phospholipids from the inner leaflet of the bilayer, and processing of existent 
glycoproteins (Jones, 1998). Over 200 proteins have been identified in epididymal 
fluid, many of which are specific to different regions of the epididymis (Dacheux et 
al., 1998). The epithelial-sperm signalling and ionic changes that initiate and control 
these complex events are far from understood. The presence of P2X receptors on 
immature sperm, but not mature sperm may indicate a role for purinergic signalling in 
sperm maturation. Ionic changes induced by stimulation of P2 receptors may be 
important in either maintaining epididymal fluid composition, or facilitating sperm 
membrane changes. This is supported by human studies on ejaculated sperm that have 
shown ATP rapidly induces the acrosome reaction, and that the mode of action is 
through the action of Na+ channels and is Ca2+ independent. Functional in vitro 
fertilisation studies using sperm from patients with male factor infertility, 
demonstrated a significantly higher fertilisation rate, when the acrosome reaction was 
induced by exogenous ATP (Foresta et al., 1992; 1996; Rossato et al., 1999).
Seminal fluid has a relatively high ATP content, which has generally been viewed 
as an energy substrate (Singer et al., 1983) and although reduced seminal ATP levels 
are implicated in infertility (Irvine et al., 1985), investigative studies have failed to
125
find a correlation between seminal ATP and infertility (Mieusset et al., 1989; Vigue et 
al., 1992; WHO, 1992). Sperm are known to have high mitochondrial content based 
around the midpiece of the spermatozoa and synthesise their own ATP with the result 
that seminal fluid ATP levels remain very constant in the presence of substrates for 
ATP synthesis (Jeulin and Soufir, 1992; Minelli et al., 1999). The ATP content of 
epididymal fluid has not yet been confirmed, but possible sources of ATP include 
ATP released from viable sperm, or ATP released from apoptotic sperm. Further 
possibilities include release from the epididymal epithelium, as ATP and adenosine 
have been shown to be released from Sertoli cells as well as germinative and myoid 
peritubular cells of the seminiferous tubules (Gelain et al., 2003). Neurogenic release 
may be a further source of ATP as it is known to be co-released with NA and ACh in 
the stimulation of smooth muscle contraction of the genital tract (Bumstock, 2001; 
Banks et al., 2005). Previous studies have demonstrated the importance of neurogenic 
innervation to the epididymal fluid composition (Ricker, 1996).
The loss of receptor expression in the distal epididymidis was clearly evident, and 
may imply that the receptor is altered, possibly following stimulation, resulting in loss 
of expression, which,may be part of a negative feedback loop. Alternatively the 
expression may be masked by a proteinacous substance present in distal epididymal 
fluid. Several studies have demonstrated the presence of proteins specific to regions 
of the epididymis (Young et al., 1985; Jones 1987; Gatti et al., 2004), which may have 
an inhibitory role (Turner and Giles, 1982). The persistence of P2X* in the distal 
cauda epididymidis would suggest that masking is not universal or receptor alteration 
is more likely.
This study has demonstrated the expression of several P2X receptors on the heads 
of immature epididymal sperm in 4 different species, which shows a high degree of
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species similarity. This expression appears to be lost on more mature sperm in the 
distal epididymidis although this is incomplete for P2 X4 receptors in man. This may 
suggest that ATP has an extracellular signalling role in the complex process of sperm 
maturation.
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CHAPTER 6
ALTERATIONS IN PURINERGIC AND 
CHOLINERGIC COMPONENTS OF 
CONTRACTILE RESPONSES OF ISOLATED 
DETRUSOR CONTRACTION IN A RAT MODEL 
OF PARTIAL BLADDER OUTFLOW 
OBSTRUCTION
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6.1 Abstract
Following 3 weeks of partial bladder outlet obstruction, the rat bladders 
became significantly hypertrophied and doubled in weight. Spontaneous activity 
was markedly increased, but the contractile response to a single bolus of potassium 
chloride (120 mM) was unaltered. The neurogenic-induced contractile responses of 
strips of detrusor from obstructed bladders were significantly greater than those of 
sham-operated bladders, with the responses of strips of detrusor from obstructed 
bladders to electrical field stimulation showing a significantly greater atropine- 
sensitive component compared to sham-operated detrusor. However, the response 
of detrusor strips to EFS that was susceptible to desensitisation by a,P-meATP, 
was not significantly changed in obstructed bladders. The sensitivity of the strips 
of detrusor from obstructed bladders to carbachol, ATP and P,y-ATP was reduced 
with respect to sham-operated detrusor. Immunohistochemical studies did not 
show a difference in the P2X receptor subtypes expressed on detrusor smooth 
muscle from obstructed and sham-operated rats.
In the rat, following moderate bladder hypertrophy, the atropine sensitive 
component was significantly up-regulated, but the ATP sensitive component was 
marginally reduced, although not significantly. In conclusion, these results suggest 
that up-regulation of the P2X component of bladder contraction seen in humans 
with symptoms of bladder overactivity, and in other species models of bladder 
obstruction, is not mirrored in the rat, or occurs later in the pathological process of 
bladder hypertrophy.
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6.2 Introduction
Bladder overactivity represents a massive health and economic problem with 
symptoms affecting up to 9 million people over 40 years old in the UK (McGrowther, 
2004). The condition of bladder overactivity is characterised by involuntary bladder 
contractions causing pressure rises during bladder filling, which result in a strong and 
uncontrollable urge to pass urine, which often leads to incontinence (Abrams et al., 
1990). The mechanisms underlying bladder overactivity are poorly understood. It is 
clear that there are marked species differences in the proportions of the cotransmitters 
ACh, ATP in the parasympathetic nerves supplying the bladder of different species 
including man (see Bumstock, 2001). In the healthy human bladder, the purinergic 
component of parasympathetic cotransmission is minor, although P2 receptors are 
present on the smooth muscle. However, in pathologically overactive bladders, the 
purinergic component has been shown to account for up to 50% of the contraction 
(Palea et al., 1993; Bayliss et al., 1999; O’Reilly et al., 2002). A significant increase 
in the purinergic component of detrusor contraction was also seen in a rabbit model of 
partial bladder obstruction (Calvert et al., 2001). In a rat model, however, sensitivity 
to purinergic receptor agonists was shown to be reduced following 10 days of 
obstruction (Sjuve et al., 1995) and in a long-term rat obstruction model, only the 
cholinergic element of EFS-induced detrusor contractions was increased (Lluel et al., 
2002). Animal models of bladder outlet obstruction must be interpreted with caution 
as they may represent the response to acute retention and subsequent detrusor failure, 
as indicated by bladder weight increases of several hundred percent and reduced 
contractile responses to potassium chloride (KC1). In the present study, the effects of 
partial bladder outlet obstruction on the cholinergic and purinergic components of 
contraction of the rat detrusor were investigated.
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6.3 Methods
6.3.2 Induction of partial bladder outlet obstruction.
Female Sprague-Dawley rats weighing 173-220g were anaesthetised using a 
mixture of halothane and oxygen. Under sterile conditions, a lower midline incision 
was made, the peritoneum was mobilised cranially and the pre-vesical fat was 
retracted to expose the bladder neck and urethra running on the ventral surface of the 
vagina. A 1 mm section of proximal urethra was mobilised approximately 2-3 mm 
from the bladder neck. Care was taken to avoid mobilising the bladder neck to prevent 
damage to bladder neck nerves. Similarly, care was taken to avoid puncturing the 
large peri-urethral veins. Following successful mobilisation of the urethra, a jeweller’s 
silver ‘jump’ ring with an internal diameter of 1 mm was passed around the urethra 
and closed exactly. The ring remained lose on the urethra and did not appear to cause 
immediate obstruction. The bladder was then gently squeezed to ensure it was not 
fully obstructed and that the urethra had not been punctured. The bladder and wound 
were irrigated with saline to prevent drying and the formation of adhesions. In most 
situations it was possible to perform the operation without entering the peritoneal 
cavity. The wound was closed with absorbable suture, local anaesthetic (0.3ml 0.25 % 
marcaine), and a single dose of analgesic (.28 ml temgesic) was administered. The 
rats were observed overnight in a designated recovery room, and then returned to 
normal livery conditions with food and water ad libitum the following day. Sham- 
operated female rats underwent an identical procedure without placement of the ring. 
Rats were sacrificed under Schedule 1 guidelines at 3 weeks ± 2 days.
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6.3.2 In Vitro Pharmacology
See general methods, Chapter 2
Bladders were weighed intact following division at the urethra-bladder neck 
junction. The bladder was divided immediately above the level of the ureters to 
exclude the bladder neck. The remainder of the bladder was then pinned and divided 
into strips measuring approximately 3 x 20 mm. 3 pM indomethacin was added to the 
all Krebs solutions in order to reduce the spontaneous detrusor activity. An initial load 
of 1 g was applied to the preparations. Despite allowing the preparations at least 1 hr 
to stabilise, pilot studies found that initial responses to EFS from partially obstructed 
bladder preparations were inconsistent, and contractions often increased following the 
first frequency-response curve, subsequent frequency-responses were more consistent. 
Therefore control contractions were repeated 3 times to ensure reproducibility. The 
contractions from the last two frequency-response curves were averaged to give a 
control contraction.
Non-cumulative concentration response curves were constructed using CCh 
(0.01 jiM-0.3 mM), ATP (0.1 pM-1 mM) and p,y-meATP (0.1 pM-0.3 mM). A single 
concentration of KC1 (120 mM) was applied at the end of the experiment. The bladder 
strips were weighed following completion of the experiment.
6.3.3 Immunohistochemistry
See general methods Chapter 2. All P2X receptor antibodies diluted to 2.5-
5|i.g/ml.
132
6.4 Results
6 . 4 . 1  P r o c e d u r e  t o l e r a b i l i t y  /  r a t  g r o w t h .  Partial bladder obstruction did not 
adversely affect rat growth as assessed by the mean weight increase over 3 weeks 
(sham-operated 22.5 ± 3.7, partial bladder obstruction 27.6 ± 3.9 g, P = 0.4). Two rats 
died approximately 3 days post procedure from urinary retention. In both cases the 
ring was closed so that it overlapped very slightly. In all further cases the ring was 
closed exactly. It was important to do this, as even the tiniest gap resulted in failure of 
the procedure to induce bladder hypertrophy. No other post-operative complication 
was observed and the procedure appeared to be very well tolerated. It was not 
necessary to massage bladders in the immediate post-operative period to facilitate 
voiding as in other studies (Lluel et al., 2002).
6 . 4 . 2  B l a d d e r  w e i g h t . The mean weight of sham operated rat bladders was 70.3 ±
1.3 mg. The partially obstructed rat bladders were significantly heavier at almost 
exactly double the weight of sham-operated rats at 141.8 ± 14.5 mg (un-paired 
Student t- test P = 0.0016), (Figure 6.1a). Detrusor strip weight was 11.1 ±0.7  mg 
from sham-operated rats and 16.6 ± 0.8 mg from partial bladder obstruction rats.
6 . 4 . 3  R e s p o n s e  t o  K C l .  There was no significant difference in the response of 
detrusor strips from sham-operated or obstructed rats to a standard concentration of 
KCl (120 mM). Sham detrusor 0.182 ± 0.019 g per g of tissue and obstructed bladder 
0.179 ± 0.011 g per g of tissue (Figure 6. lb).
6 . 4 . 4  R e s p o n s e  t o  E l e c t r i c a l  F i e l d  S t i m u l a t i o n .  EFS induced TTX-sensitive 
frequency- dependent contractions. Small TTX-insensitive contractions were
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observed at the higher frequencies consistent with direct muscle stimulation. All 
results are adjusted for this. The contractile responses of obstructed detrusor to EFS 
were significantly greater with respect to sham-operated detrusor. The mean peak 
contraction at 16 Hz was 80% greater in obstructed rat detrusor, (111.3 +/- 12.8 % 
and 62.5 +/- 11.7 % contraction of KCl response, obstructed and sham detrusor 
respectively) (Two way ANOVA P = 0.0015), (Figure 6.2).
6 . 4 . 5  A t r o p i n e  s e n s i t i v e  c o m p o n e n t  o f  E F S  i n d u c e d  c o n t r a c t i o n .  The percentage 
of control contraction inhibited by atropine (1 pM) was greater for obstructed rat 
detrusor at all frequencies tested and increased with increasing frequency. Maximal 
inhibition occurred at 16 Hz and amounted to an 81 % reduction in contraction (range 
42-81 %). The percentage of initial contraction inhibited by atropine (1 pM) in sham- 
operated rats also increased with increasing frequency, but was less, and at 16 Hz 
amounted to 47 % (range 24-56 %). (Two way ANOVA, P = 0.0013), (Figure 6.2).
6 . 4 . 6  P u r i n e r g i c  c o m p o n e n t  o f  E F S  i n d u c e d  c o n t r a c t i o n  ( a , f i - m e A  T P  d e s e n s i t i s e d  
c o m p o n e n t ) .  The percentage of control detrusor contraction inhibited following 
desensitisation with a,P-meATP (2 xlOO pM) was greater in sham-operated rats with 
respect to obstructed rats. This component was constant in sham-operated rats at a 
mean inhibition of 73 % (Figure 6.3a). In obstructed rats, the a,P-meATP (2 xlOO 
pM) induced inhibition was more variable and inconsistently increased with 
frequency. At 0.5 Hz inhibition was 50 % and at 32 Hz was 70 %, mean inhibition 
was 62 % (Figure 6.3b). The difference in the purinergic components was not 
significant. (Two way ANOVA, P = 0.16).
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The combination of atropine (1 pM) and a,P-meATP (2 xlOO pM) caused 
significantly greater inhibition in partially obstructed rats. In partially obstructed rats 
virtually no contraction was observed under these circumstances (Figure 6.3b), 
however in the sham-operated rats some residual contraction was observed at the 
higher frequencies tested (Figure 6.3a).
6 . 4 . 7  S e n s i t i v i t y  t o  c a r b a c h o l .  Detrusor strips contracted in a concentration- 
dependent manner to CCh (0.01 pM-0.3 mM). The sensitivity of detrusor strips from 
obstructed rats to CCh was significantly reduced with respect to sham-operated rats. 
The EC50 was 0.96 pM (95 % Cl = .9-1.0 pM) for sham-operated rats and 3.0 pM (95 
% Cl = 2.5-3.5 pM)for obstructed rats, (Two way ANOVA, P = 0.001), (Figure 6.4a).
6 . 4 . 8  S e n s i t i v i t y  t o  p u r i n e r g i c  a g o n i s t s .  Detrusor strips contracted in a 
concentration dependent manner to both ATP (0.1 pM-1 mM) and P,y-meATP (0.1 
pM-0.3 mM). The sensitivity to the most stable purinergic agonist P,y-meATP was 
significantly less in the obstructed rats (Two way ANOVA P = 0.0078), (Figure 6.4b). 
The responses of detrusor strips to ATP were smaller than those for P,y-meATP. The 
sensitivity to ATP was also significantly reduced in the obstructed rats (Two way 
ANOVA P = 0.0031) (Figure 6.5).
6 . 4 . 9  I m m u n o h i s t o c h e m i s t r y .  P2Xi receptor expression was observed on the 
detrusor smooth muscle membrane from both sham-operated and control rats. There 
was no discemable difference in the expression (Figure 6.6). Minimal expression of 
P2XZ receptor was observed within smooth muscle cells from either group. P2 X3 
receptor expression was observed in a subepithelial position in both groups. No
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smooth muscle expression was observed. Some expression of P2 X4 receptors was 
observed on the transitional epithelial cells from both groups. Expression of P2 X5 
receptors was not observed. Some expression of P2X6 receptors was observed on the 
basal membrane from both groups. No expression of P2 X7 receptors was observed.
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6.4 Results 
Figure 6.1
(a) Comparison of bladder weights (mg) from sham-operated controls to partial 
bladder obstruction rats. Bars represent mean ± s.e. (sham-operated, n=5, 
partial bladder obstruction, n=6).
(b) Comparison of tension generated by KCl (120 mM) on detrusor strips from 
sham-operated controls (strips=24, n=5) and partial bladder obstruction rats 
(strips =31, n=6).
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Figure 6.2
Frequency-response curve showing contraction to EFS, (100 V, 0.3 ms, 0.5-32 
Hz, 20 s) of sham-operated control (B)(n=5) and partial bladder obstruction (•)(n=6) 
strips of detrusor. Subsequently, in the presence of atropine (IpM), sham-operated 
(□), partial bladder obstruction (o). All symbols show mean % contraction of the KCl 
response (120 mM) ± s.e. (unless masked by symbol). All data shown has been 
adjusted to subtract the TTX insensitive component. ★ indicates significance, 
(P=<05).
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Figure 6.3
(a) Sham-operated
(b) Partial bladder obstruction
Frequency-response curves showing initial contraction to EFS, ( 1 0 0  V, 0.3 ms, 
0.5-32 Hz, 20 s) of either sham-operated (a) or partial bladder obstruction (b) strips of 
detrusor (•). Subsequently following desensitisation with a,P-meATP (■) (sham, 
n=5), (partial bladder obstruction, n=6 ), in the presence of atropine (lp.M)(o) or in the 
presence of both atropine (lpM ) and following desensitisation with a,p-meATP (A). 
All symbols show mean % maximum contraction ± s.e. (unless masked by symbol). 
All data shown has been adjusted to subtract the TTX insensitive component.
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Figure 6.4
(a) Concentration-response curve for CCh, Sham-operated controls (■, n=5), red 
dotted line (—) indicates 95 % Cl for Sham-operated control values. Partial 
bladder obstruction (•, n=6 ), green dotted line (---) indicates 95 % Cl for 
individual values.
(b) Concentration-response curve for |3,y-meATP. Sham-operated controls 
(■, n=5) and partial bladder obstruction (•, n=6 ).
All symbols show the mean % of the contraction to KCl (120 mmol) ± s.e. (unless 
masked by symbol) and non-linear regression curve where concentration-response 
curve reached maximal contraction. ★ indicates significance, (P=< 05).
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Figure 6.5
Concentration-response curve for ATP.
Sham-operated controls (■, n=5) partial bladder obstruction (• , n=6 ).
All symbols show the mean % of the contraction to KCl (120 mmol) ± s.e. (unless 
masked by symbol). ★ indicates significance, (P=< 05).
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Figure 6.6
All scale bars=50 jjM
a. High power photomicrograph demonstrating P2Xi receptor expression on 
membrane of detrusor smooth muscle of sham operated control rats. No 
epithelial expression was observed.
b. High power photomicrograph demonstrating P2Xi receptor expression on 
membrane of detrusor smooth muscle of partial bladder obstruction rats. 
No epithelial expression was observed.
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Figure 6.6
SHAM OBSTRUCTED
6.5 Discussion
The rat model of partial bladder outflow obstruction has been shown to cause 
detrusor overactivity (Malmgren et al., 1987; O’Connor et al., 1997). In some studies, 
very large bladder mass increases and reduced KCl responses have been reported 
(Lluel et al., 2002). These studies must be interpreted with caution, as they may be 
more representative of the recovery response of the bladder to acute obstruction. The 
partial bladder obstruction model in the current study was well tolerated and resulted 
in a relatively mild increase in bladder mass with evidence of genuine detrusor 
hypertrophy, increased nerve-mediated contraction and marked spontaneous activity. 
As a consequence of the hypertrophy the obstructed strip size was slightly heavier but 
small differences in detrusor strip size have not been shown have a significant effect 
on tension responses (Longhurst et al., 1995). Macroscopically the bladder detrusor 
smooth muscle and epithelium were thickened. Hypertrophy was confirmed 
histochemically. There was no deterioration in smooth muscle contractility as 
assessed by the contractile response to KCl. In our study the cholinergic component of 
the nerve-induced contraction accounted for up to 80 % in obstructed bladders, 
although only 50 % in sham-operated bladders. The purinergic component was 
reduced, although not significantly. In a longer, 12 week bladder outlet obstruction 
model in the rat, a significant increase in the cholinergic component and a non­
significant increase in the purinergic component were observed, but the contraction to 
KCl was significantly reduced indicating reduced bladder contractility (Lluel et al., 
2002).
Purinergic co-transmission in the contraction of the bladder smooth muscle of 
many animals is well documented (Bumstock, 2001). In the normal human bladder it 
is thought to have a minimal contribution to normal physiological contraction (Bayliss
147
et al., 1999). However, P2X receptors are expressed on normal human detrusor 
smooth muscle, and contractile function was observed to exogenous ATP (O’Reilly et 
al., 2002). Human studies are challenging due to difficulty in confirming bladder 
overactivity, and ensuring that controls represent normal tissue. A number of studies 
have suggested that the purinergic component of human bladder contraction is 
substantially up-regulated in the pathological state. The purinergic co-transmission 
component is increased to account for 40 % of the contraction in interstitial cystitis 
(Palea et al., 1993), up to 50 % in idiopathic female detrusor overactivity (O’Reilly et 
al., 2 0 0 2 ), and in cases of proven bladder overactivity, significant up-regulation has 
been demonstrated (Bayliss et al., 1999). It has been shown that the purinergic 
component of human bladder contraction is increased and the cholinergic component 
reduced with age (Yoshida et al., 2001). Another study contradicts this, suggesting 
that the purinergic component, as assessed by antagonism, is 5% in overactive 
detrusors and 3% in controls, with a significant up-regulation of the myogenic or TTX 
resistant component in overactive bladder tissue (Mills et al., 2000). The up- 
regulation of the purinergic component cannot be explained by altered sensitivity, as 
detrusor myocytes from stable and unstable bladders were equally sensitive to 
cholinergic and purinergic agonists (Wu et al., 1999). A reduction in ecto-ATPase 
enzyme activity has been demonstrated from unstable or obstructed human bladders 
and this may account for the increased potency of ATP in these pathological states 
(Harvey et al., 2 0 0 2 ). Increased expression of the P2X2 receptor has been 
demonstrated in detrusor overactivity (O’Reilly et al., 2002).
The increase in the cholinergic component of detrusor contractility seen in the 
present study cannot be explained by denervation supersensitivity, since although the 
nerve-stimulated response was raised, the response to exogenous CCh was decreased.
148
Brading (1997) has suggested that a feature of bladder overactivity is denervation 
supersensitivity, in which there is a reduction in the number of excitatory nerves and a 
reduction in acetylcholinesterase (AChE), resulting in agonist supersensitivity. In 
contrast it has been suggested that there is an increase in cholinergic nerve 
proliferation in bladder outlet obstruction (Steers et al., 1990; 1991). It has been 
proposed the relative ratio of parasympathetic cotransmitters can change in 
pathological conditions (Bumstock, 2001). A study into the neuroanatomical changes 
of hypertrophied rat detrusor demonstrated a modest increase in PGP staining nerves 
around smooth muscle bundles, but minimal change within the smooth muscle 
bundles. In contrast nerves expressing AChE within the bundles were reduced, though 
between bundles were unchanged (Sutherland et al., 1998). In another rat study of 
mild obstruction, no change in choline acetyltransferase expression was observed, and 
no dysfunction in responses to EFS (Levin et al., 1993). In the present study, the 
neurogenic atropine-sensitive component was increased, which would be consistent 
with a reduction in AChE. However, it does not explain the reduced sensitivity to 
CCh, although the CCh sensitivity would be independent of AChE due to being non- 
hydrolysable. The sensitivity to all agonists tested was reduced, which would suggest 
a common change in contractile mechanism. In previous rat models, the detrusor has 
been shown to rapidly adapt to partial outflow obstruction, with bladder weight 
increasing up to 12 fold in 6  weeks, with the fastest growth rate being at 3 days 
following obstruction (Uvelius et al., 1984a; Sutherland et al., 1998). The growth is 
mainly accounted for by smooth muscle hypertrophy, with the smooth muscle cross 
section increasing significantly. The collagen content also increased, but the relative 
concentration was reduced to 1/3 of control levels. The smooth muscle bundles were 
preserved, with the collagen increase being mostly between bundles with minimal
149
collagen infiltration within bundles (Uvelius et al., 1984b; 1991). It therefore seems 
unlikely that the reduced sensitivity to all exogenous agonists seen in the present 
study could be explained by tissue fibrosis obstructing agonist permeability. The 
response to KC1 was similar which would suggest that there was no fundamental 
change in the smooth muscle contractility. Our observations, therefore suggest a 
change in the expression of receptors or transduction mechanisms.
The rat bladder is known to express several P2X receptor subtypes, with the 
strong expression of P2Xi receptors on detrusor smooth muscle (Lee et al., 2000). In 
the present study no difference was observed between normal and obstructed bladder 
in the expression of P2X receptor subtypes. Subtype expression concurred with 
previous reports (Lee et al., 2000). In the awake rat, bladder contraction was induced 
by ATP, and then reduced following pre-treatment with oc,P-meATP (Igawa et al., 
1994). Similarly in the P2Xi receptor-deficient mouse, despite expression of other 
subtypes of P2X receptors, no detrusor contractions were recorded to the P2X 
agonists ATP, a,P-meATP and P,y-meATP. This was further supported by patch- 
clamp studies on detrusor smooth muscle demonstrating no effect on the holding 
current in P2Xi receptor-deficient mice. The bladders of P2Xj receptor-deficient mice 
were functionally and morphologically normal. It was thought that the cholinergic 
element of the bladder contraction was sufficient to maintain function (Vial and 
Evans, 2000). This is in contrast to contraction of the vas deferens from P2Xi 
receptor-deficient mice, which was found to be markedly reduced, resulting in 
infertility (Mulryan et al., 2000). The evidence would strongly suggest that the 
functional P2X receptor involved in smooth muscle contraction in rat, mouse and 
probably human bladder is the P2Xi subtype. In the rabbit testis where a,P-meATP is 
less potent than ATP, the dominant P2X receptor subtype may be the P2X2 subtype
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(Banks et al., 2006). The function of other P2X subtypes expressed in smooth muscle 
is less clear, as is the functional role of the suggested heteromultimers P2 Xi/s and 
P2X i/2- The P2X3 receptor has been shown to have a mechano-sensory role in 
micturition in mice, and P2X3 receptor null mice demonstrated bladder hyporeflexia 
(Cockayne et al., 2000; Rong et al., 2002). There was no discemable reduction in the 
expression of P2X receptors. It is therefore possible that the marginally reduced 
neurogenic purinergic component may be due to either reduced ATP release or 
increased ecto-ATPase activity.
This study has shown that the cholinergic component of rat detrusor contraction is 
enhanced in mild obstruction and the purinergic component is marginally reduced. 
This is in contrast to the rabbit and human in which the reverse occurs. This study 
would suggest that the rat detrusor adapts to obstruction in a different manner to that 
of man, or that purinergic up-regulation is not a feature of early adaptation.
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CHAPTER 7 
GENERAL DISCUSSION
In this chapter, I have attempted to put the results into a broader context and I 
have addressed certain points raised in the course of this study. I have discussed the 
extent of testing of my hypothesis, and have discussed the limitations of the 
techniques used. I have addressed some of the inevitable questions that arise from this 
study, and have suggested some further lines of investigation.
The main aspects that I will discuss are, the species conformity in the presence 
of smooth muscle in the tunica albuginea of the testis, the significance of the direct 
innervation seen in human tissue and the presence of purinergic signalling in the 
contraction of this smooth muscle. I will address the significance of the presence of 
P2X receptors in the contraction of the human tunica albuginea and vas deferens and 
suggest the possibility of a ‘testis-epididymis-vas deferens sperm pump’ propelling 
sperm through the genital tract. I will comment on the possible role of purinergic 
signalling in sperm maturation, and on the potential of purinergic signalling in male 
contraception. Finally, I will address the use of a rat model of partial bladder outlet 
obstruction to replicate the upregulation of purinergic signalling seen in human 
detrusor overactivity.
In order to examine the role of purinergic signalling in the testicular capsule, it 
was important to clarify the extent of smooth muscle in the tunica albuginea as there 
has been little published on this topic since the initial interst in the early 1970s. 
Electron microscopy confirmed a high level of species similarity in both the 
appearance of the smooth muscle cells, and their arrangement in sheets. Secretory 
phenotype smooth muscle cells were observed in the outer part of the tunica albuginea 
which presumptuously secrete the collagen that give the tunica albuginea its tough
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capsule, with contractile phenotype smooth muscle cells on the inner aspect 
presumably being responsible for functional contraction. This arrangement was 
present in man and was similar to the other species examined, and may be common to 
the tunica albuginea of all mammals. The smooth muscle arrangement appeared to be 
a continuum and did not support the suggestion of a defined inner contractile smooth 
muscle layer (Middendorf et al., 2002). It was significant to demonstrate the neuronal 
innervation of human smooth muscle, which has not been shown previously, and was 
not seen in the other species studied. The demonstration of specialised close junctions 
between the long processes of the smooth muscle cells would suggest myogenic 
propagation of neuronal stimuli and the possibility of the tunica albuginea contracting 
as a syncytium. Central to my hypothesis was the role of purinergic signalling in the 
genito-urinary tract, and this study demonstrated that contraction of the tunica 
albuginea to purinergic agonists was common to all species examined. However, 
other autonomic stimuli were less consistent between species. In man, it is likely that 
ATP is co-released with NA, and that human tunica albuginea contraction is under 
sympathetic nervous system control alone. This is in contrast to the mouse in which 
the contraction is under parasympathetic cholinergic control, with adrenergic 
stimulation resulting in smooth muscle relaxation. In the rat and rabbit cholinergic, 
adrenergic and purinergic agonists contracted the tunica albuginea. Purinergic 
signalling is thought to represent a primitive signalling system (Burnstock, 2 0 0 1 ), and 
the fact that it was common to all the the species examined may support that it was a 
primitive common signalling pathway that has evolved to be coupled with other 
transmitter systems depending on reproductive behaviour. Whilst I have demonstrated 
purinergic signalling in the tunica albuginea it was unfortunately beyond the remit of 
this study to examine the importance of tunica albuginea contraction in the movement
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of sperm out of the testis. Despite the demonstration that testicular capsulotomy 
causes infertility and the subsequent degeneration of seminiferous tubules (Qin and 
Lung, 2000a; b), it is still uncertain whether testicular contractions are essential to the 
movement of sperm out of the testis, and consequently whether such contractions are 
significantly implicated in infertility.
In contrast, the significance of purinergic signalling to the movement of sperm 
in the mouse vas deferens has been clearly demonstrated by oligospermic infertility in 
P2Xi knockout mice, however, the role of purinergic signalling to the contraction of 
the human vas deferens was essentially unknown. This study has clearly demonstrated 
the presence of purinergic cotransmission in the contraction of the human vas 
deferens. The expression of P2Xi and P2 X2 receptors on the outer longitudinal and 
middle circular layers conforms to the arrangement seen in other species; however, it 
is not clear why there is no expression on the inner longitudinal muscle layer. 
Previous studies in labaroratory animals have shown differing contractile response 
profiles to nerve stimulation (Furness and Bumstock, 1969). Comparison of the 
relative adrenergic and purinergic components of human vas deferens contraction 
would suggest that the adrenergic component dominates. This may be the reason the 
human vas deferens contracts to nerve stimulation in a relatively slow monophasic 
manner, without an initial fast peak due to significant ATP release, as seen in some 
laboratory animals. This significant difference between man and mouse would 
suggest that P2Xi antagonism alone would not result in infertility, and that comments 
suggesting such antagonism would be contraceptive in man may have been premature 
(Lincoln, 2000; Mulyran et al., 2000).
In the course of background reading for this thesis it was surprising not to find 
an objective study examining when the smooth muscle of the vas deferens or tunica
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albuginea contracts. The three layered tubular structure of the vas deferens implies 
peristalsis, but this has not been clearly demonstrated, and one study in dogs 
suggested that sections of vas deferens contract as a whole, rather than in a peristaltic 
wave (Kimura et al., 1975). In the epididymis there is increasing tubule musculature 
from proximal to distal which is supportive of peristaltic propulsion of sperm, but 
objective evidence is lacking. Radiographic studies have demonstrated antegrade and 
retrograde movement of radio-opaque dye within the vas deferens with storage in the 
cauda epididymis (Prins and Zaneveld, 1980; Kihara et al., 1995). It is also unclear 
whether contractions are continuous or occur in response to specific stimuli. It was an 
interesting observation that rabbit tunica albuginea demonstrated spontaneous 
contractions, but in man, spontaneous contractions of the tunica albuginea and vas 
deferens only occurred following prior stimulation. The fact that ejaculates contain 
sperm, despite sexual abstinence suggests a continuous flux of sperm through the 
genito-tubular system. This has led me to question whether there is a ‘tunica 
albuginea-epididymis-vas deferens sperm pump’, continually contracting to move 
sperm from the testis, through the epididymis and finally along the vas deferens into 
the ejaculatory ducts in preparation for ejaculation. It is likely there is antegrade and 
retrograde movement to prevent senescence of sperm. I would suggest that larger 
volumes of sperm are moved in response to adrenergic and purinergic induced 
contraction of smooth muscle, secondary to sympathetic discharge in states of arousal. 
The demonstration of direct neurogenic innervation in man adds weight to the 
requirement for sympathetic stimulation for human tunica albuginea contraction, as 
opposed to a preponderance of background myogenic contraction.
The role of purinergic signalling in smooth muscle spontaneous contraction 
frequency is an area of general investigation. P2X2 receptors have been demonstrated
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on interstitial cells of Cajal in the vas deferens and intestine and it has been suggested 
that they have a pacemaker function on smooth muscle contraction (Burton et al., 
2000; Bumstock and Lavin, 2002). In the present study, ATP increased the rate of 
spontaneous vas deferens contractions, even when applied at an insufficient 
concentration to evoke a contraction, which in conjunction with the 
immunohistochemical demonstration of P2X2 receptors is supportive of a pacemaker 
role for P2X2 receptors. This role may also be important in the tunica albuginea where 
immunohistochemical expression of P2X2 receptors appeared stronger than that of 
P2Xi receptors. Futher evidence for neural control for sperm transport comes from 
sympathetic denervation studies that demonstrated significantly lower daily sperm 
counts in the presence of normal testis function (Consentino et al., 1984). Partial 
sympathetic denervation was also shown to alter rat cauda epididymal fluid protein 
content, independent of sperm accumulation (Ricker et al., 1996). It was also shown 
that sperm from sympathetically denervated rat cauda epididymides had normal 
potential for fertility, but embryo development was inhibited (Ricker, 1997). This 
would suggest that there may be an optimum maturation period within the epididymis 
and that prolonged epididymal transit time may be detrimental to sperm as 
demonstrated by poor sperm quality in spinal injury patients (Brackett et al., 2000; 
Utida et al., 2005)
An obvious limitation of this thesis is that whilst I have shown the presence of 
P2X receptors and contraction of genital smooth muscle to purinergic stimuli, I have 
not demonstrated that such contractions move sperm. A number of essential studies 
are needed to determine normal sperm transport from the testis to the epididymis and 
subsequently the vas deferens. The essence of these would be to investigate the 
presence of peristaltic waves within the genital tract. The simplest would be in vitro
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whole testis pressure recordings, which our own pilot studies suggested were possible. 
Microcannulae and subcutaneously implanted pressure transducers have been 
successfully used during in vivo urodynamic studies. Such techniques could be used 
to record pressure waves from the different parts of the genital tract. This basic, but 
essential knowledge is critical to our understanding of sperm transit. Alternatively, 
radiolabelled studies have the potential to track the continuous movement of sperm. It 
is possible that such techniques might be useful in diagnosing genital tract smooth 
muscle dysfunction in man in a clinical setting. The role of purinergic signalling in 
genital tract dysfunction will be much harder to confirm, as it would be ethically 
impossible to examine vas deferens from patients with possible vas deferens 
dysfunction, as it is essential for the possibility of natural conception. It would also be 
extremely difficult to create an animal model of purinergic vas deferens dysfunction, 
without denervating the tract, although the P2Xi knockout mouse can be considered 
such a model. The Mulyran paper sparked interest into the possibility of an, as yet, 
elusive selective P2Xi receptor antagonist as the male contraceptive pill (Mulyran et 
al., 2000; Dunn, 2000). Whilst such a treatment may be successful in the veterinary 
field, the predominance of the adrenergic system in man is likely to limit its 
therapeutic usefulness, and it would need to be in combination with adrenergic 
antagonism to be effective. A P2Xi or P2 X2 receptor stimulant preferably in 
combination with an adrenergic stimulant would potentially increase sperm flux 
through the genital tract and would be potentially useful in the treatment of 
oligospermia. Such a treatment might compensate for reduced spermatogenesis. Two 
case series suggest a successful outcome of treatment with sympathomimetic agents 
in vas deferens aperistalsis, although the accuracy of such a diagnosis must be 
questioned (Tiffany and Goldstein, 1985; Tillem and Mellinger, 1999). A simple
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starting point would be to see if semen parameters, particularly total numbers and 
concentration, in normal subjects could be improved by freely available 
sympathomimetics such as pseudoephedrine (Sudafed®). Such a trial would lend 
itself to a placebo-controlled, double-blind crossover study.
The positive expression of P2X receptors on sperm contained within the 
proximal epididymis and the subsequent loss of expression in the distal epididymis is 
suggestive of a trophic role for ATP in sperm maturation. Although expression varied, 
it was demonstrated in four different species including man, in a very similar pattern, 
which may imply a common phenomenon. Human studies would benefit from 
examining epididymides from younger patients. The clinical importance of this 
expression remains to be elucidated. Functional studies would be extremely difficult 
to undertake due to the lack of understanding of the epididymal milieu and sperm 
interaction with it. Rossato, in her study demonstrated higher fertility rates with 
ejaculated sperm incubated with ATP, which was suggestive of a clinically important 
function for P2X receptors (Rossato et al., 1999). The development of several P2X 
receptor subtype null mice gives an insight into the functional significance of receptor 
subtypes. The P2Xi receptor null mouse was infertile due vas deferens aperistalsis, 
but sperm were fertile in an in vitro setting (Mulyran et al., 2000). There are no 
reports of infertility associated with the other knockout mice studies, P2 X2, P2 X2/3, 
however, full reproductive details of these animals have not been reported 
(Vlaskovska et al., 2001; Coutinho-Silva et al., 2005). On the evidence available, it 
would seem that the expression of P2X receptors during spermiogenesis and 
maturation is not critical for fertilisation. Fertilisation depends on adequate 
communication between a mature and competent sperm and a similar female oocyte. 
The acrosome of sperm is a mosaic of glycoprotein domains and the fluid nature of
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the membrane means that there is the potential for extremely rapid movement and 
incorporation of glycoproteins and molecules. Ion channels are instrumental in the 
dialogue between a sperm, its environment, and an egg. The ability of sperm to swim 
to, and fertilise an egg, is modulated by ion permeability changes induced by 
environmental stimuli in both male and female genital tracts, together with 
components of the outer layer of the egg. Calcium is probably the key messenger in 
this information exchange. Certain sperm ion channels are turning out to be unique 
(Ren et al., 2001) of which a P2 channel may yet be one. These channels make them 
attractive targets for contraception as antagonisation would hinder fertilisation rather 
that either spermiogenesis or the transport of sperm with their probable hormonal or 
ejaculatory side effects. New approaches to measure sperm currents, particularly with 
the advent of nanotechnology, will allow previously impossible patch clamp studies 
of sperm. The same technology could also be used to measure currents at epithelial 
microvilli and may elucidate epididymal epithelium-sperm interactions (Gorelik et al., 
2002). The presence of ATP within the epididymal and seminal fluid suggests it may 
have a role in exocrine cell signalling in the complex membranous changes that occur 
firstly in spermiogenesis, and secondly in the processes resulting in fertilisation. The 
measurement of epididymal fluid ATP concentrations within the different epididymal 
sections would give valuable information in support of a role in sperm maturation. 
Isolating the role of purinergic signalling on the maturational membrane changes 
undergone by epididymal sperm would appear extremely difficult.
It was my hypothesis that purinergic signalling seen in the genito-urinary tract 
of laboratory animals may differ from that of man. I have demonstrated that 
purinergic signalling is important in the contraction of human, mouse, rat and rabbit
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tunica albuiginea. I have also demonstrated human vas deferens contraction has a 
significant purinergic component, but that this is proportionally less than published 
reports in laboratory animals and is likely to be functionally less significant than the 
dominant adrenergic component. Purinergically mediated and/or modulated 
contraction of gental tract smooth muscle may be of significance in the propulsion of 
sperm from the testis to ejaculatory ducts. I have also demonstrated a P2X receptor 
basis for a possible trophic role for ATP in sperm maturation in the epididymis. The 
pattern and receptor subtype expression was loosely consistent between man and the 
labaratory animals investigated, which may be representative of differing sperm 
transit times through the epididymis.
Purinergic signalling has been implicated is human detrusor overactivity. 
Animal models of bladder outlet obstruction are well established in this field, and 
have shown plasticity of the purinergic component. Human studies in this field are 
difficult because of ethical considerations in obtaining sufficient amounts of detrusor 
tissue, difficulties in confirming pathological states, and ensuring normal tissue is 
indeed normal. Furthermore, problems of matching even basic patient characteristics, 
such as age, . This is highlighted in a paper by Harvey, in
which the subsets of unstable bladders and obstructed bladders were combined to 
generate greater numbers (Harvey et al., 2002). In Chapter 6  it was hoped to replicate 
an earlier bladder obstruction study in the rabbit which had demonstrated purinergic 
upregulation (Calvert et al., 2001). One possibility to explain purinergic upregulation 
is an increase in the receptor density, and it was intended to examine whether up­
regulation of the purinergic component occurred as a result of increased P2X receptor 
expression. The bladder outlet obstruction model was successfully applied to the rat, 
and undoubtedly induced detrusor overactivity. Indeed some of the spontaneous
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activity of obstructed tissue was greater than the evoked contractions of sham- 
operated controls. The study demonstrated a significant up-regulation of the 
cholinergic component rather than the purinergic component and no discemable 
difference in the P2X receptor expression. This model confirmed neurogenic 
plasticity in detrusor overactivity, however, the rat model of obstruction did not 
appear to be representative of human tissue. This highlights the difficulty of using 
animal models to replicate a human disease process. In man, detrusor overactivity 
usually develops insidiously and covers a spectrum of symptoms and signs, which do 
not necessarily correlate. This rat model induced rapid detrusor hypertrophy and 
instability over 3 weeks.
The field of purinergic signalling continues to be hampered by the paucity of 
receptor specific antagonists. P2X knockout mice help to circumnavigate this 
problem, but neurogenic plasticity may mean that the impact of absent receptors is 
masked by compensatory adaptation, as possibly demonstrated by normal bladder 
function in P2Xi knockout mice. The P2 X3 knockout mouse has demonstrated 
hyporeflexia of the bladder. More recent developments, using antisense 
oligonucleotides (ASO) and double stranded, short interfering RNAs (siRNA) to the 
P2 X3 receptor gene, have demonstrated significantly reduced pain responses in rat 
chronic pain models, confirming the role of P2 X3 receptors in inflammatory pain and 
possibly suggesting a therapeutic vehicle (Barclay et al., 2002; Dorn et al., 2004). In 
detrusor overactivity it is possible that up-regulation of purinergic signalling may be 
of more therapeutic relevance to the sensory mechanisms than to the contractile 
mechanisms. The possibility of ‘damping down’ bladder afferents by antagonism of 
P2 X3 receptors is currently an exciting possibility receiving serious attention from 
pharmaceutical companies. The new field of gene array may greatly help to examine
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up or down regulation of the genes encoding the purinergic receptors and help 
elucidate their function in pathological situations. Furthermore, the possibility of 
nanotechnology pipettes in conjunction with patch-clamping has the potential to 
unravel the ionic messages of P2X receptors and the cross talk with other signalling 
systems.
In this study I have confirmed the presence and function of P2X receptors on 
the smooth muscle of the human testis and vas deferens as well demonstrating a 
possible trophic role for purinergic signalling in sperm maturation. Although the 
general pattern of P2X receptor expression was similar between man and the 
laboratory animals examined or previously studied, the role of purinergic signalling in 
contraction of human genito-urinary muscle appeared less significant. Although 
receptor plasticity was demonstrated in the pathological bladder model used, it was 
not possible to confirm purinergic dysfunction in the genito-urinary tract.
Currently there are no P2X pharmaceutical agents on the formulary. The 
P2 Yi2 receptor antagonist, clopidigrel, is now in widespread use as an anti-thrombotic 
agent and has had such a significant impact on stroke prevention and vascular graft or 
stent success that it is the third biggest blockbuster drug on the market (Economist, 
2005). The fields of bladder overactivity and infertility represent billion pound 
markets. Purinergic modulation continues to offer therapeutic potential and I would 
suggest that it is only a matter of time before a P2X receptor agent joins its illustrious 
cousin on the formulary.
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